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Abstract
The endoplasmic reticulum (ER) functions as a protein folding factory, where
polypeptide chains gain their native structure. Disruption of ER homeostasis,
referred as ER stress, induces a cellular response called the unfolded protein
response (UPR). In the context of obesity, UPR induced by high concentrations
in lipids appears as a key actor in the development of insulin resistance in liver
and adipose tissue. However, the mechanism of lipid-induced ER stress remains
unclear and, the causal link between UPR and insulin resistance is controversial
in skeletal muscle. In a first part, we investigated whether a plasma membrane
receptor namely the toll-like receptor 4 (TLR4) could be a mediator of lipid-
induced ER stress. Wild-type and TLR4-/- mice were fed with standard chow or
high-fat diet (HFD). As shown by the UPR-regulated protein BiP, TLR4-/- mice
were protected against ER stress induced by HFD in skeletal muscle, liver and
adipose tissue. Contrary to our hypothesis, this does no...
Document type : Thèse (Dissertation)
Référence bibliographique
Pierre, Nicolas. Regulation of ER stress and insulin pathway by lipids in skeletal muscle.  Prom. :
Francaux, Marc
   
  
  
  
 
 
 
 
 
 
 
Regulation of ER stress and insulin 
pathway by lipids in skeletal muscle 
 
 
Nicolas Pierre 
 
 
Thèse présentée en vue de l’obtention du grade 
de Docteur en Sciences de la Motricité 
 
 
Promoteur: Prof. Marc Francaux 
 
 
Louvain-la-Neuve 
2014 
 
 
Université catholique de Louvain 
 
Institute of Neuroscience 
 
Muscle and Exercise Physiology 
research group 
 
  
 JURY 
 
 
 
Chair: 
Prof. Jean-Louis Thonnard, Université catholique de Louvain, 
Belgium 
 
 
Supervisor: 
Prof. Marc Francaux, Université catholique de Louvain, Belgium 
 
 
Committee: 
Prof. Pascal Ferré, Université Pierre et Marie Curie, France 
Prof. Patrice Cani, Université catholique de Louvain, Belgium 
Dr. Xavier Wittebole, Université catholique de Louvain, Belgium  
Prof. Jean-Paul Thissen, Université catholique de Louvain, Belgium  
Prof. Luc Bertrand, Université catholique de Louvain, Belgium 
 
 
  
  
  
  
Remerciements 
 
Cette recherche est le fruit d’un travail collectif. A travers ces quelques lignes, je 
souhaiterais destiner mes plus chaleureux remerciements à celles et ceux qui ont, de 
près ou de loin, participé à cette aventure.  
 
En premier lieu Marc, mon promoteur, je tiens à t’exprimer toute ma gratitude pour 
ton investissement et ton suivi stimulant durant ces six années. En tant que professeur 
ou promoteur, merci de transmettre ta passion et ton enthousiasme pour la science. 
Jean-Marc, merci de m’avoir encadré et encouragé les premières années de ma thèse. 
Nos discussions scientifiques m’ont accompagné tout au long de mes recherches. 
 
Ma reconnaissance s’adresse ensuite aux membres de mon comité d’accompagnement: 
Jean-Louis Thonnard, Patrice Cani, Jean-Paul Thissen, Xavier Wittebole, Luc 
Bertrand. Je vous remercie pour vos critiques constructives et les éclairages que vous 
avez apportés lors de la défense privée. Merci également à Pascal Ferré, vos 
remarques m’ont permis d’explorer des mécanismes physiologiques dont je ne 
soupçonnais pas l’existence. 
 
A mes débuts au laboratoire, Louise, Cécile et Hermann ont été mes guides. Merci à 
vous pour avoir partagé votre savoir-faire et vos idées. 
Je remercie également l’équipe CARD de Luc Bertrand pour m’avoir si bien accueilli, 
plus particulièrement merci à Audrey, Julien et Edith. 
 
J’ai eu beaucoup de plaisir à collaborer avec Caroline, Pauline et Simon dans le cadre 
de leurs mémoires. Un grand merci pour votre investissement généreux et nos 
nombreux échanges stimulants. 
 
 
 
  
 
Ensuite, mes remerciements s’adressent à mes amis et collègues du laboratoire: Julie, 
Damien, Céline, Bénédicte. Merci pour votre aide technique, scientifique et aussi pour 
les bons moments, moins sérieux, passés ensemble.   
Je tiens également à remercier toutes les personnes qui participent au bon 
fonctionnement de l’unité mais aussi à la convivialité de la cafétéria: Sabine, Nico B, 
Jonathan, Simon, Sophie, Fabian, Elodie, Thierry M, Madeleine, Pascale, Marie-Jo; et 
les anciens: David, Mathieu, Charles, Gan-Li.  
Je tiens à remercier tout particulièrement Rodrigo. Merci « amigo » pour toutes les 
améliorations, de fond et de forme, que tu as apportées au texte. Cette thèse comporte 
une touche Chilienne. 
 
Pendant ces six années, j’ai également eu la chance d'enseigner dans de bonnes 
conditions. C'est pourquoi, je remercie les membres de la FSM, particulièrement 
Thierry M et Marc, qui m’ont toujours donné toute leur confiance. 
 
Merci à tous ces professeurs passionnés qui, tout au long de mes études, ont stimulé ma 
curiosité et m’ont donné l’envie de comprendre. 
 
Enfin, il reste à m’adresser à ceux qui me donnent le courage et l’inspiration. Bien 
qu’ils ne liront probablement jamais cette thèse, ils y sont intégralement associés. 
Merci à toute ma famille et mes amis.  
Je ne pourrais terminer ces remerciements sans parler de toi, Claire. Toujours là, 
partageant doutes et joies. Merci pour tout. 
 Table of contents 
 
List of abbreviations 1 
 
Introduction 7 
 
Chapter 1: Endoplasmic reticulum: from homeostasis 7 
to stress response  
 
1.1. General overview 7 
1.2. Endoplasmic reticulum 8 
1.3. Endoplasmic reticulum as a protein folding factory 9  
1.4. Unfolded protein response 13 
 
Chapter 2: Potential mechanisms of lipid-induced 19 
endoplasmic reticulum stress 
 
2.1. Toll-like receptor 4 and endoplasmic reticulum stress 19 
  
 2.1.1. Historical overview of toll-like receptor discovery 19 
 2.1.2. Toll-like receptor 4 activation and signaling pathways 20 
 2.1.3. Activation of toll-like receptor 4 by saturated lipids 24 
 2.1.4. Regulation of endoplasmic reticulum stress by  27 
  toll-like receptor 4 
 
2.2. Oxidative stress and endoplasmic reticulum stress 28 
in muscle cells 
 
 2.2.1. Hydrogen peroxide homeostasis 28 
 2.2.2. Induction of oxidative stress by lipids 32 
 2.2.3. Oxidative stress and endoplasmic reticulum stress:  34 
  a vicious circle 
 
2.3. Membrane lipid composition and 36 
endoplasmic reticulum stress 
 
 
 
 
 
  
Chapter 3: Mechanisms of lipid-induced 39  
insulin resistance in muscle cells 
 
 3.1. Regulation of glucose uptake by insulin 39 
 3.2. Inhibition of insulin-stimulated glucose uptake by lipids: 42   
 the never ending story 
 3.3. Inhibition of insulin pathway by 48 
 endoplasmic reticulum stress 
 
Chapter 4: Aims of the thesis 53 
 
Chapter 5: Toll-Like receptor 4 knockout mice 65 
are protected against endoplasmic reticulum  
stress induced by a high-fat diet  
 
Chapter 6: Activation of ER stress by 97  
hydrogen peroxide in C2C12 myotubes 
 
Chapter 7: IRE1α and TRB3 do not contribute   
to the disruption of insulin signaling caused  
by palmitate in C2C12 myotubes 
 
Chapter 8: Discussion, limitations and conclusion 115 
 
8.1. Discussion 115 
  
 8.1.1.  Regulation of endoplasmic reticulum stress, 115  
  body mass, and insulin sensitivity  
 by toll-like receptor 4 
 8.1.2. Endoplasmic reticulum stress induced 126  
   insulin resistance in muscle cells: what is wrong? 
 8.1.3.  Immunometabolism: an evolutionary point of view 136 
 
8.2. Limitations 139 
 
8.3. Conclusion 144 
 
Abbreviations  
List of abbreviations 
 
AP-1   activator protein 1 
ATF/CREB  activating transcription factor/cyclic AMP 
response element binding protein 
ATF3   activating transcription factor 3 
ATF4   activating transcription factor 4  
ATF6    activating transcription factor 6 
BiP/GRP78  binding immunoglobulin protein/glucose- 
   regulated protein 78 kDa 
BSA   bovine serum albumin  
bZIP   basic leucine zipper 
Cer   ceramide synthase  
CD14   cluster of differentiation 14  
CHOP   C/EBP homologous protein 
DAG   diacylglycerides 
DGAT1  acylCoA:diacylglycerol acyltransferase-1 
eIF2α   eukaryotic translation-initiation factor 2 alpha 
eIF2B   eukaryotic translation-initiation factor 2B  
ER    endoplasmic reticulum  
ERAD   endoplasmic-reticulum-associated protein  
degradation 
ERKs   extracellular signal-regulated kinases 
ERO1   endoplasmic reticulum oxidoreductin-1-like  
   protein 
ERSE   ER stress response element 
FAD   flavin adenine dinucleotide 
2  Abbreviations 
 
FB1   fumonisin B1  
FetA   fetuin-A 
GCN2   general control non repressed 2 
GLUT4  glucose transporter 4 
GPx   glutathione peroxidase 
GRP94  glucose-regulated protein 94 kDa 
GSH   glutathione reduced 
GSSG   glutathione oxidized  
GSVs   GLUT4 storage vesicles 
HFD   high-fat diet 
HRI   heme-regulated inhibitor  
HSP40   heat-shock protein 40 kDa 
HSP70   heat-shock protein 70 kDa 
HSP90   heat-shock protein 90 kDa 
IκBα   NF-κB inhibitor alpha 
IFNβ   interferon beta 
IFNγ   interferon gamma 
IKK   IκB kinase 
IL-1   interleukin 1 
IL-6   interleukin 6 
IMTG   intramyocellular triglycerides 
IP3Rs   inositol trisphosphate receptors 
IR   insulin receptor 
IRAK   interleukin-1 receptor-associated kinase  
IRE1    inositol-requiring 1 
IRF3   interferon regulatory factor 3 
IRS    insulin receptor substrate  
Abbreviations  3 
 
 
IRESs   internal ribosomal entry sites 
ITT   insulin tolerance test 
JNKs    c-Jun amino-terminal kinases 
LBP   lipopolysaccharide binding protein 
LPS   lipopolysaccharide  
LRR   leucine-rich repeats 
MAM   mitochondria-associated ER membrane  
MAMPs  microorganism associated molecular patterns 
MAPKs   mitogen-activated protein kinases  
MCP1   monocyte chemotactic protein 1 
MD-2   myeloid differentiation protein 2 
MKK   mitogen-activated protein kinase kinase 
mTORC2  mammalian target of rapamycin complex 2 
MyD88  myeloid differentiation primary response  
   protein 88  
NADPH  nicotinamide adenine dinucleotide phosphate  
NEFA   non-esterified fatty acids 
NOX   NADPH oxidase  
NF-κB   nuclear factor kappa B  
NRF2   nuclear factor erythroid 2-related factor 2  
OGTT   oral glucose tolerance test 
OL   oleate 
PA   palmitate 
PBA   4-phenyl butyric acid  
PDH   pyruvate dehydrogenase 
PDI   protein disulfide isomerase 
PDK1   phosphoinositide-dependent kinase-1 
4  Abbreviations 
 
PERK   double-stranded RNA-dependent protein kinase  
   (PKR)-like ER kinase 
PGC-1α  proliferators-activator receptor gamma  
   coactivator-1 alpha 
PH   pleckstrin homology 
PI3K    phosphatidyl inositol 3-kinase  
PIP2   phosphatidylinositol 4,5-diphosphate 
PIP3   phosphatidylinositol 3,4,5-trisphosphate  
PKCζ   protein kinase C zeta 
PKCθ   protein kinase C theta  
PKR   double-stranded RNA-dependent protein 
PL   phospholipids 
PLA2   phospholipase A2 
PP2A   protein phosphatase 2A 
PRRs   pattern recognition receptors 
PTB   phosphotyrosine binding  
RER   rough endoplasmic reticulum 
RIP-1   receptor-interacting protein 1 
ROS    reactive oxygen species  
RyR1   ryanodine receptor 1 
S1P   site-1 protease 
S2P   site-2 protease 
SCD   stearoyl-CoA-desaturases 
SEAP   secreted alkaline phosphatase 
SER   smooth endoplasmic reticulum 
SERCA1a  sarco/endoplasmic reticulum Ca2+ ATPase 1a 
SH2   Src homology 2 
Abbreviations  5 
 
 
SOD   superoxide dismutase 
SPT   serine palmitoyltransferase 
SR   sarcoplasmic reticulum 
TAB   TAK-binding proteins 
TAD   transcriptional activating domain 
TAK1   transforming growth factor-beta-activated  
   kinase 1 
TBC1D1  TBC1 family member 1 
TBC1D4/AS160 TBC1 family member 4/Akt substrate 160 kDa 
TBK1   TANK-binding kinase 1 
TC   ternary complex 
TG   triglycerides 
TIR   toll/interleukin-1 receptor 
TIRAP   TIR domain-containing adapter protein 
TNFR   tumor necrosis factor receptor 
TRAF6  TNF receptor associated factors 6  
TRAM   TRIF-related adapter molecule    
TRB3   tribbles homolog 3 
TRIF   TIR domain-containing adapter-inducing 
   interferon-β 
TLR3   toll-like receptor 3 
TLR4   toll-like receptor 4 
TNFα   tumor necrosis factor alpha 
TUDCA  tauroursodeoxycholic acid 
Ubc13   ubiquitin-conjugating enzyme 
uORFs   upstream open reading frames   
UPR   unfolded protein response 
6  Abbreviations 
 
Uev1A   ubiquitin-conjugating enzyme   
WT   wild-type 
XBP1s   X box-binding protein 1, spliced form 
XBP1u  X box-binding protein 1, unspliced form 
XO   xanthine oxidase 
 
 
Endoplasmic reticulum: from homeostasis to stress response 7 
 
 
Introduction 
From stapedius to sartorius, skeletal muscle accounts for about 
40% of the total body mass. To produce motion, skeletal muscle 
operates as a motor, which converts chemical energy into mechanical 
work and heat. Skeletal muscle consumes mainly lipids in basal state 
as well as during moderate physical exercise (Weber, 2011). In 
modern society, reduction of physical exercise combined to high 
energy intake results in a whole body energy storage in the form of 
fat. In the context of obesity, extracellular and intracellular lipids act 
as an endogenous toxicant for muscle cells. Lipotoxicity is causally 
associated with insulin resistance, the principal feature of type 2 
diabetes. Recent advances allowed to identify innate immune system 
and endoplasmic reticulum as key players in lipid-induced insulin 
resistance.  
 
Chapter 1: Endoplasmic reticulum: from homeostasis to 
stress response 
 
1.1. General overview 
All living organisms as well as virus use proteins in vast array of 
biological process. Proteins are polymers of units called amino-acids. 
Linear amino-acids chain is a non-functional structure; protein 
performances are attributed to their complex three-dimensional shape. 
In eukaryotic cells, protein folding is mainly achieved in the cytosol 
and the endoplasmic reticulum (ER). ER lumen provides a unique 
environment enabling complex reaction which would be impossible in 
the cytosol. This compartmentalization is essential to fold secreted and 
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membrane proteins. Inside the ER, cells have evolved a complex 
machinery to maintain proteostasis (protein homeostasis). A quality 
control system checks whether proteins are properly folded. Unfolded 
proteins are degraded either through proteasome or autophagy, 
whereas correctly folded proteins are exported to the Golgi apparatus. 
Equilibrium between protein load and folding capacity is delicate. 
When this balance is upset by physiological or pathological process, 
unfolded proteins accumulate leading to disturbance of ER 
homeostasis, this disorder is known as ER stress. To cope with this 
stress, ER triggers a homeostatic pathway known as unfolded protein 
response (UPR). After describing the ER and the folding machinery, 
we will examine UPR signaling. 
 
1.2. Endoplasmic reticulum 
ER is a vast eukaryotic organelle surrounding the nucleus. It forms 
a network of tubules, vesicles and cisternaes delimited by a membrane 
in continuity with the nucleus. One part of the ER is covered by 
ribosomes which directly synthesize proteins into the ER lumen. This 
type of ER is called rough endoplasmic reticulum (RER) since the 
presence of ribosome makes it visually granular. RER is specialized in 
the folding of secreted and membrane proteins. RER is more abundant 
in cells which produce a large amount of secreted proteins (e.g., 
hepatocyte, plasmocyte, pancreatic β-cells). In contrast to RER, the 
smooth endoplasmic reticulum (SER) referred to an ER type that is 
not covered by ribosome. The SER is mainly associated with lipid 
synthesis. The smooth and striated muscle exhibit a subtype of SER, 
the sarcoplasmic reticulum (SR). SR has an essential function in 
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muscle contraction, storing calcium and releasing it in response to 
action potential. Lastly, depending on the cellular context, ER 
structures are dynamically interchangeable. 
 
1.3. Endoplasmic reticulum as a protein folding factory 
A thought experiment known as Levinthal's paradox highlights the 
fascinating performances of the cellular folding machinery. A protein 
of one hundred amino-acid residue, which theoretically has 999 
possible conformation, is correctly folded on a subsecond timescale 
(Stevens and Argon, 1999). Furthermore, the crowded ER 
environment, about 100 mg.ml-1 of macromolecules, makes 
challenging the folding reaction since unfolded proteins tend to 
aggregate in such a concentration (Ellis and Minton, 2006, Stevens 
and Argon, 1999). Much progress has been done since the Nobel 
Prize, Christian B. Anfinsen, postulated that amino-acid chain 
contains the native structure information (Sela et al., 1957). However, 
neither computational science nor in-vitro assays are currently able to 
model or mimic the folding machinery. The protein-folding problem is 
considered as one of the most challenging question in molecular 
biology (Ben-Naim, 2012). Its understanding requires a 
multidisciplinary approach which is beyond the scope of this 
paragraph. Herein, we will focus on the specificity of ER protein 
folding. Three main elements drive the folding reaction into the ER: 1) 
folding factors; 2) oxidative environment; 3) high calcium 
concentration. 
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Protein folding reaction are catalyzed or facilitated by a large 
number of proteins. Inside the ER, around fifty proteins work in an 
assembly line called the folding pathway (Braakman and Bulleid, 
2011). These proteins accomplish multiple functions: chaperone, 
cochaperone, peptidyl prolyl cis/trans isomerase, oxidoreductase, 
glycan-binding protein, client-specific folding factor. Native proteins 
typically have hydrophobic domains buried within their core, whereas 
hydrophilic domains form a shell around the molecule. On the 
contrary, the hydrophobic domains of nascent proteins are exposed 
and tend to aggregate in an amorphous structure (Hartl et al., 2011). 
Protein aggregation culminates with the formation of a highly toxic 
structure known as amyloids fibrils (Hartl et al., 2011). To maintain 
proteostasis, unfolded proteins are segregated by chaperone, a family 
of proteins which recognize hydrophobic domains (Hartl et al., 2011). 
A molecular chaperone is defined as: “any protein which interacts, 
stabilizes or helps a non-native protein to acquire its native 
conformation but is not present in the final functional structure” 
(Hartl and Hayer-Hartl, 2009). These proteins are found in the ER as 
well as the cytosol. Among the ER-resident chaperones, the binding 
immunoglobulin protein (BiP, also known as GRP78 or HSPA5) plays 
a central role. BiP is a member of the highly conserved heat-shock 
protein 70 kDa (HSP70) families, which are expressed in probably all 
eukaryotic cells (Bangs et al., 1993). One remarkable feature of ER-
resident chaperone is their ability to perform multiple functions. For 
instance, BiP is involved in protein folding, UPR regulation, protein 
translocation, unfolded protein recognition, unfolded protein 
degradation (Hartl et al., 2011). To perform all these functions, BiP 
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cooperates with several partners such as HSP40, HSP90 and 
nucleotide-exchange factors (Buchberger et al., 2010). 
The correct folding of proteins is continually evaluated by a quality 
control system which drives proteins toward folding or degradation 
processes. Within the ER, N-glycosylation serves as tag to mark the 
state of protein folding. Most proteins are N-glycosylated once they 
enter into the ER. This post-translational modification consists of the 
addition of an oligosaccharide chain to asparagine in the consensus 
Asn-X-Ser/Thr sequon. N-glycosylation is performed by 
oligosaccharyltransferase which catalyzes the binding of a glucose3-
mannose9-N-acetylglucosamine2 glycan (Needham and Brodsky, 
2013). Two glucose molecules are rapidly removed from N-
glycosylated proteins by the enzyme glucosidase I and II, enabling the 
interaction of the polypeptide with the lectin-type chaperones, 
calnexin and calreticulin. The monoglycosylated protein follows a 
cycle of deglycosylation and glycosylation mediated by glucosidase II 
and glycoprotein glucosyl transferase respectively. Native proteins are 
deglycosylated and enter into the secretory pathway, whereas 
monoglycosylation serves as a tag for unfolded proteins. Unfolded 
proteins are eliminated by the endoplasmic-reticulum-associated 
protein degradation (ERAD) system, a cellular pathway, which 
culminates with proteasomal degradation. It seems that aggregated 
proteins are cleared by autophagy but the mechanism remains poorly 
understood (Buchberger et al., 2010). Finally, glycan binding 
stabilizes the native protein structure and increases its solubility 
(Braakman and Bulleid, 2011). 
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ER provides a unique environment enabling to drive disulfide bond 
formation. In the cell, reduced glutathione (GSH) is the principal 
redox buffer (Chakravarthi et al., 2006). Compared to cytosol, ER 
lumen is highly oxidant. The molar ratio of reduced to oxidized 
glutathione (GSH/GSSG) ranges from 1:1 to 1:3 in the ER and from 
30:1 to 100:1 in the cytosol (Hwang et al., 1992). Oxidative 
environment allows oxidation of two cysteines to form cystine, 
resulting thereby in a disulfide bridge. This reaction is catalyzed by 
the protein disulfide isomerase (PDI), which accepts electrons from 
thiol groups. Electrons are transferred to another oxidoreductase, the 
endoplasmic reticulum oxidoreductin-1-like protein (ERO1), which 
uses flavin adenine dinucleotide (FAD) as a cofactor. Then, 
ERO1/FAD complex transfers electrons to oxygen and produces 
hydrogen peroxide (Zhang and Kaufman, 2008). This source of 
oxidative molecules is not often mentioned in the literature. 
 
Calcium concentration in the ER is several thousand-fold higher 
than in the cytosol (Schroder and Kaufman, 2005). In the ER of 
muscle cells, the sarco/endoplasmic reticulum Ca2+ ATPase 1a 
(SERCA1a) regulates calcium entrance, whereas calcium exit depends 
on the ryanodine receptor 1 (RyR1) and the inositol trisphosphate 
receptors (IP3Rs) (Csordas and Hajnoczky, 2009). Furthermore, 
folding factors largely contribute to calcium storage due to their 
numerous binding sites for the cation (Braakman and Bulleid, 2011). 
For instance, it has been reported that BiP contributes to 25% of the 
ER calcium storage in HeLa cells (Lievremont et al., 1997). More 
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importantly, protein chaperone functions are highly regulated by 
calcium concentration (Schroder and Kaufman, 2005). 
 
As described above, ER protein folding depends on a subtle 
interaction between folding factors, redox status and calcium 
homeostasis. Any perturbation of one of these parameters can disrupt 
the whole folding machinery and eventually leads to ER stress. The 
well-known positive controls for ER stress, thapsigargin and 
tunicamycin, illustrate this fine regulation. Inhibition of SERCA 
pumps or N-glycosylation by thapsigargin or tunicamycin respectively 
disrupts ER homeostasis and induced a massive ER stress 
(Novosyadlyy et al., 2008).  
 
1.4. Unfolded protein response 
Accumulation of unfolded proteins into the ER lumen triggers 
UPR. In eukaryotic cells, UPR includes three pathways initiated by 
three proteins anchored in the ER membrane, the ER stress sensors: 
double-stranded RNA-dependent protein kinase (PKR)-like ER kinase 
(PERK), inositol-requiring 1 (IRE1) and activating transcription factor 
6 (ATF6). Each of these proteins is inactivated by BiP binding. Upon 
ER stress, unfolded proteins competitively recruit BiP leading to 
activation of the ER stress sensors (Zhang and Kaufman, 2008). UPR 
mediates an adaptive response via: 1) protein synthesis inhibition; 2) 
transcriptional upregulation of genes involved in protein folding, 
transport and ERAD. In the case where these homeostatic responses 
fail to restore proteostasis, UPR induced cells death through apoptosis. 
UPR signaling is illustrated in Figure 1.1. 
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The most immediate response to ER stress is the translational 
inhibition of protein synthesis (Kaufman, 2004). Upon ER stress, 
PERK homodimerizes and trans-autophosphorylates. Activated PERK 
phosphorylates the eukaryotic translation-initiation factor 2α (eIF2α) 
on serine 51, promoting global inhibition of protein translation and 
selective protein translation. The mechanism by which eIF2α 
phosphorylation prevents the initiation stage of protein synthesis have 
been well described. eIF2 complex (α, β and γ) binds to methionine 
transfer RNA and GTP to form the ternary complex (TC). This 
complex assembly is catalyzed by the guanine nucleotide exchange 
factor eIF2B, which converts inactive eIF2 (eIF2-GDP) to active eIF2 
(eIF2-GTP). Phosphorylation of eIF2α on serine 51 inhibits this 
critical step by stabilizing the inactive complex p-eIF2-GDP-eIF2B 
(Sudhakar et al., 2000). As a consequence, TC availability decreases, 
preventing the assembly of the 43S preinitiation complex. Due to the 
low cellular expression of eIF2B compared to eIF2α (10- to 20-fold 
lower), inhibition of eIF2B occurs when only 20-30% of eIF2α is 
phosphorylated (Kaufman et al., 2002, Kaufman, 2004). 
Consequently, phosphorylation of eIF2α is a key regulator of protein 
translation. 
The initiation step of translation described herein account for the 
CAP-dependent mechanism. Indeed, mRNAs are recognized by their 
5’ CAP end, which successively recruits the 43S preinitiation complex 
and the 60S ribosomal subunit to form the 80S initiation complex. The 
80S ribosomal subunit scans mRNA until to reach the start codon 
(AUG) (Hashem et al., 2013). Alternatively, unusual mRNA contains 
internal ribosomal entry sites (IRESs) enabling a CAP-independent 
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translation (Kaufman, 2004). These cis-acting elements are recognized 
by the 40S ribosomal subunit which directly starts translation, 
bypassing thereby the scanning process (Hellen and Sarnow, 2001). 
Translation of these particular mRNAs is not regulated by eIF2α 
phosphorylation. This is possibly the case for BiP mRNA, which 
contains an IRES (Kaufman, 2004). 
Paradoxically, eIF2α phosphorylation promotes translation of 
specific mRNAs by an uncommon mechanism. In eukaryotic cells, 
upstream open reading frames (uORFs) are short coding sequences 
present in 5' untranslated region. In human, studies revealed that 
~50% of the mRNAs contain at least one uORF (Barbosa et al., 2013). 
Recognition and translation of uORFs are involved in the regulation of 
translation initiation. Such mechanism has been initially characterized 
for the general control non-derepressible 4, the yeast counterpart to 
activating transcription factor 4 (ATF4). A similar regulation has been 
found for ATF4 translation response to eIF2α phosphorylation. The 
mRNA sequence of ATF4 contains two uORFs, which promote 
(uORF1) or prevent (uORF2) translation (Vattem and Wek, 2004). 
Upon eIF2α phosphorylation, the reduction in TC level increases time 
interval required for the scanning ribosome to reinitiate translation at 
uORF2. This delay allows the ribosomal machinery to skip the 
inhibitory uORF2 and instead translate the ATF4-coding region 
(Vattem and Wek, 2004). Thanks to these mechanisms, a single 
regulator, eIF2α, controls both selective translation and global 
translation inhibition. In addition to translational control, UPR 
regulates ATF4 expression at a transcriptional level (Dey et al., 2010). 
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ATF4 is a transcription factor, which controls most of the effects of 
the PERK pathway (Schroder and Kaufman, 2005).  
In addition to eIF2α, PERK phosphorylates the transcription factor 
nuclear factor erythroid 2-related factor 2 (NRF2). Phosphorylation of 
NRF2 by PERK induced its translocation into the nucleus. 
 
The IRE1 pathway is the only UPR branch conserved from yeast to 
mammalian (Walter and Ron, 2011). In mammalian, two IRE1 
paralogs are expressed: IRE1α and IRE1β. IRE1α exhibits ubiquitous 
expression, whereas IRE1β expression is restricted to intestinal 
epithelial cells (Iwata and Koizumi, 2012). Activation of IRE1α 
follows a chronological step, homodimerization then trans-
autophosphorylation. These steps are required to activate both 
functions of IRE1α: kinase and endoribonuclease. When activated, 
IRE1α triggers a subtle mechanism to regulate activity of the 
transcription factor X-box-binding protein 1 (XBP1). Such regulation 
is mediated by a splicing independent of the spliceosome machinery. 
The unspliced XBP1 (XBP1u) mRNA contains two ORFs partially 
overlapping (Yoshida et al., 2001). In non-stressed conditions, only 
the first ORF (ORF1) is translated into a weak transcription factor. 
Upon ER stress, IRE1α RNase activity results in the splicing of 26-
base intron in the overlapping ORFs sequence, generating the spliced 
form of XBP1 (XBP1s) (Yoshida et al., 2001). Excision of this 
intronic sequence causes a translational frameshift, which in turn 
induced a partial translation of both ORFs. The resulting protein 
contains a basic leucine zipper (bZIP) domain coded by ORF1 and a 
transcriptional activating domain (TAD) encoded by ORF2 
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(Nagashima et al., 2011). The presence of a TAD increases drastically 
XBP1 transcriptional activity (Yoshida et al., 2001). Although non-
intuitive, removal of bases from XBP1 transcript results in a protein 
with a longer amino acid sequence (Iwata and Koizumi, 2012).  
 
The third UPR signaling is initiated by ATF6. In mammalian, all 
the cells express two ATF6 isoforms, ATF6α and ATF6β (Malhotra 
and Kaufman, 2007a). Upon ER stress, ATF6 translocates to the Golgi 
apparatus where it is cleaved by two proteases, the site-1 and site-2 
(S1P and S2P) proteases. The proteolysis results in the release of a 
fragment containing the bZIP domain of ATF6. This fragment 
migrates to the nucleus and activates transcription (Zhang and 
Kaufman, 2008).  
 
UPR-regulated transcription factors recognize DNA through a bZIP 
domain. They act alone or as homodimers or as heterodimers, which 
are themselves regulated by co-activators and co-repressors (Schroder 
and Kaufman, 2005). These trans-elements, which bind to cis-
elements, constitute the distal step of UPR. XBP1 and ATF6 seem to 
converge toward the consensus mammalian ER stress response 
element (ERSE) to control the transcription of chaperones such as BiP 
and the glucose-regulated protein 94 kDa (GRP94) (Schroder and 
Kaufman, 2005). ATF4 binds to the activating transcription 
factor/cyclic AMP response element binding protein (ATF/CREB) site 
and regulates the transcription of genes encoding proteins involved in 
antioxidant defense and amino acid biosynthesis (Malhotra and 
Kaufman, 2007a, Schroder and Kaufman, 2005). ATF4 and ATF6 
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regulate ER stress-induced apoptosis through induction of the C/EBP 
homologous protein (CHOP) (Zhang and Kaufman, 2008). Finally, 
activation of the antioxidant response element by NRF2 regulates the 
transcription of antioxidant proteins such as subunits of glutathione S-
transferase and NAD(P)H:quinone oxidoreductase (Malhotra and 
Kaufman, 2007a). 
 
In conclusion, eukaryotic cells evolved complex mechanisms to 
efficiently fold proteins in a highly specialized organelle, i.e., ER. In 
addition, ER itself is able to defend against stresses through a double-
edged weapon, UPR, promoting both survival and the apoptotic death 
programme. 
 
 
Figure 1.1. UPR signaling. See details in the text. 
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Chapter 2: Potential mechanisms of lipid-induced 
endoplasmic reticulum stress 
 
2.1. Toll-like receptor 4 and endoplasmic reticulum stress 
 
2.1.1. Historical overview of toll-like receptor discovery 
In 1985, Toll gene was first identified as crucial for Drosophila 
embryogenesis (Anderson et al., 1985). Mutation of this gene induces 
dorsalized embryos. When the Nobel Laureates Christiane Nüsslein-
Volhard observed these abnormal embryos she exclaims: “Das war ja 
toll !” which means in German “That was amazing !”, and she gave 
the name “Toll” to the mutated gene (Hansson and Edfeldt, 2005). At 
the end of the 1980s, it has been found that Drosophila Toll gene 
encodes a transmembrane protein (Hashimoto et al., 1988). 
Interestingly, this protein exposes a large extracellular domain that 
contains leucine-rich repeats (LRR), a consensus sequence involved in 
protein-ligand interaction (Kobe and Kajava, 2001). In 1996, at the 
molecular and cellular biology institute of Strasbourg, Jules Hoffman's 
team showed that a deletion of the Drosophila Toll gene reduced 
survival to fungal infection (Lemaitre et al., 1996). This discovery 
associated for the first time Toll gene to host defense and was recently 
rewarded with a Nobel Prize. One year later, the Human Genome 
Project allowed to identify a human equivalent of the Drosophila Toll 
protein, now called toll-like receptor 4 (TLR4) (Medzhitov et al., 
1997). In the wake, Poltorak et al. (1998) discovered that TLR4 
mutated mice are resistant to endotoxemia induced by 
lipopolysaccharide (LPS), a gram-negative bacterial cell wall 
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component also called endotoxin (Poltorak et al., 1998). This 
established for the first time that LPS is a TLR4 ligand. All together, 
these discoveries stimulated research on the innate immune system 
and led to identify the TLRs family. To date, thirteen mammalian 
TLRs have been described. The TLRs belong to a large family of 
proteins, the pattern recognition receptors (PRRs) which recognize 
highly conserved molecules from pathogens. These molecules are 
known as microorganism associated molecular patterns (MAMPs) 
(Kaisho and Akira, 2006).  
 
2.1.2. Toll-like receptor 4 activation and signaling pathways 
Besides its expression on immune cells, TLR4 has been found in 
adipose tissue, liver and skeletal muscle (Reyna et al., 2008, Gustot et 
al., 2006, Song et al., 2006). TLR4 is a transmembrane protein. Its 
extracellular N-terminal region consists of LRR modules with a 
horseshoe-like shape, a motif involved in LPS recognition. On the 
cytosolic side of the receptor, the C-terminal region exposes a 
Toll/interleukin-1 receptor (TIR) homology domain orchestrating the 
downstream signal (Park et al., 2009).  
 
Activation of TLR4 by LPS requires a complex coordination of 
three accessory proteins (Miyake, 2006): LPS binding protein (LBP), 
cluster of differentiation 14 (CD14) and myeloid differentiation 
protein 2 (MD-2). Circulating LPS associates with LBP, a carrier 
protein synthetized by the liver and the lung. On cell-surface, LBP 
transfers LPS to CD14. This co-receptor presents LPS to the complex 
TLR4/MD-2. Crystal structure analysis has revealed interaction 
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between LPS and the receptor complex (Park et al., 2009). LPS 
binding to TLR4/MD-2 heterodimer induces the formation of a 
multimeric receptor composed of two TLR4/MD-2/LPS complexes 
(Figure 2.1). This complex is internalized into the cytosol, where it 
initiates the downstream signaling (Kawai and Akira, 2010).  
 
 
Figure 2.1. Crystal structure of the TLR4-LPS-MD-2 complex (Park et al., 2009) 
 
The interactions between the TIR domain of TLR4 and cytosolic 
adaptor proteins initiate TLR4 signaling. Activated TLR4 recruits four 
adaptor proteins: myeloid differentiation primary response protein 88 
(MyD88), TIR domain-containing adapter protein (TIRAP), TIR 
domain-containing adapter-inducing interferon-β (TRIF), and TRIF-
related adapter molecule (TRAM). TLR4 triggers two distinct 
pathways: MyD88-dependent and a MyD88-independent pathways 
(also called TRIF-dependent pathway). These pathways are illustrated 
in Figure 2.2. 
 
Except TLR3, all TLRs activate the MyD88-dependent pathway 
(Patel et al., 2012). Indeed, the production of several cytokines is 
blocked in MyD88 knockout mice stimulated with TLR ligands 
(Takeda and Akira, 2004). MyD88-dependent cascade culminates 
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with the activation of two pro-inflammatory transcription factors: 
nuclear factor-κB (NF-κB) and activator protein 1 (AP-1). These final 
effectors control the transcription of cytokines such as tumor necrosis 
factor α (TNFα), interleukin 1 (IL-1) and interleukin 6 (IL-6) (Takeda 
and Akira, 2004). 
LPS binding to TLR4 leads to the recruitment of a complex formed 
by MyD88 and TIRAP. This complex associates with two other 
partners, the interleukin-1 receptor-associated kinase 1 and 4 
(IRAK1/4). Phosphorylation of IRAK1 by the kinase IRAK4 enables 
the association of IRAK1 with the TNF receptor associated factors 6 
(TRAF6). The IRAK1/TRAF6 complex separates from the receptor 
and binds with the transforming growth factor-β-activated kinase 1 
(TAK1) and the TAK-binding proteins, TAB1 and TAB2. Activation 
of TAK1 by TRAF6 is mediated by the ubiquitin-conjugating 
enzymes, Ubc13 and Uev1A (Wang et al., 2001). Activated TAK1 
stimulates NF-κB and AP-1 activity through phosphorylation of the 
IκB kinase (IKK) and the mitogen-activated protein kinases (MAPKs) 
respectively. The MAPKs family consists of three kinase subfamilies: 
extracellular signal-regulated kinases (ERKs), c-Jun amino-terminal 
kinases (JNKs) and p38. Activation of TAK1 (also called MAP3K7) 
leads to the MAPK phosphorylation which in turn promotes AP-1 
transcriptional activity (Karin, 1995). In the cytosol, NF-κB binds to 
the NF-κB inhibitor alpha (IκBα) preventing its nuclear translocation. 
Activated TAK1 phosphorylates IKK complex (IKKα, IKKβ, IKKγ), 
which in turn phosphorylates IκBα. Subsequently, phosphorylated 
IκBα is polyubiquitinated and then degraded by the proteasome 
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system. Once liberated from IκBα, NF-κB can translocate to the 
nucleus and acts as a transcription factor (Takeda and Akira, 2004).  
 
MyD88 adaptor does not mediate all the TLR4 downstream 
signaling. In MyD88 knockout macrophages, LPS induces the 
production of interferon gamma (IFNγ) (Kawai et al., 2001). It is now 
well established that TLR4 activates the interferon regulatory factor 3 
(IRF3) through a MyD88-independent pathway. In response to LPS, 
TLR4 recruits TRAM and TRIF through their TIR-domain. This event 
initiates a signaling cascade resulting in the activation the IKK-related 
kinases IKKε and the TRAF associated NFκB activator TANK-
binding kinase 1 (TBK1). These kinases phosphorylate IRF3 leading 
to its nuclear translocation, where it promotes the transcription IFN-
inducible genes such as IFNβ and IFNγ (Clark et al., 2011). 
 
Finally, TLR4 activation induced a delayed activation of NF-κB 
and AP-1 known as the late-phase response. In other word, 
redundancy exists between the MyD88-dependent and -independent 
pathways. TRIF recruits TRAF6 and the receptor-interacting protein 1 
(RIP-1) leading to NF-κB and AP-1 activation (Kawai and Akira, 
2010). 
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Figure 2.2. TLR4 signaling pathways. See details in the text. 
 
2.1.3. Activation of toll-like receptor 4 by saturated lipids 
As its name suggests, LPS is made of lipid and glycan. This 
biomolecule comprises three parts covalently linked: O-antigen, core 
polysaccharide and lipid A. Lipid A is responsible for most of the 
biological activities of LPS. Biologic or synthetic lipid A reproduces 
the effect of LPS. Lipid A structure is highly conserved among gram-
negative bacteria; typically two glucosamines phosphorylated and 
acylated by four lipid chains, two of them are acylated with two other 
lipids (Figure 2.3). Lipid A contains six lipid residues, all of them are 
saturated (Raetz, 1990).  
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Figure 2.3. LPS from Brucella spp (Cardoso et al., 2006) 
 
This hydrophobic region plays a key role in LPS recognition by 
TLR4 since deacylated lipid A loses its endotoxic activity (Munford 
and Hall, 1986). All together, these observations had suggested that 
saturated lipids could be a TLR4 ligand. In 2001, a study 
demonstrated for the first time that saturated but not unsaturated non-
esterified fatty acids (NEFA) activate TLR4 in raw 264.7 
macrophages (Lee et al., 2001). This result was confirmed and 
extended to 3T3-L1 preadipocytes (Shi et al., 2006). In 2009, Errige et 
al. (2009) casts a doubt on NEFA recognition by TLR4 in vitro 
(Erridge and Samani, 2009). The authors showed that bovine serum 
albumin (BSA), widely mixed with NEFA in cells culture, is 
contaminated with TLR4 ligands. The authors concluded: “LPS and 
lipopeptide contamination of the widely used reagent fatty-acid-free 
BSA explains the previously reported stimulation of TLR2 and TLR4 
by SFAs”. This conclusion hides important nuances. In this study, 
three different BSA were used: low endotoxin BSA, fatty acid-free 
BSA and standard BSA. Only the fatty acid-free BSA stimulated 
TLRs signaling. Since Lee et al. (2001) used fatty acid-free and low 
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endotoxin BSA, their findings are probably not an artefact due to BSA 
contamination. Furthermore, in our lab, we showed that palmitate 
(16:0) without BSA stimulates TLR4 signaling in C2C12 myotubes 
(Zbinden-Foncea et al., 2012). Similar results were reported in 
RAW264.7 macrophages (Huang et al., 2012). 
NEFA recognition by TLR4 is also supported by in vivo 
experiments. Some studies showed that TLR4-/- knockout mice are 
protected against insulin resistance induced by lipid infusion or high-
fat diet (HFD) (Shi et al., 2006, Tsukumo et al., 2007).  
 
The mechanism by which NEFA binds to TLR4 remained elusive 
until 2012. In 2001, Lee et al. (2001) already suggested the presence 
of an intermediate molecule between NEFA and TLR4: “Whether 
saturated fatty acids can directly interact with TLR4 or they interact 
with molecules associated with either extracellular or intracellular 
domains of TLR4 remains to be determined”. Recently, such 
intermediate molecule has been identified. Pal et al. (2012) 
demonstrated that NEFA alone did not bind to TLR4, this interaction 
needs a third partner called fetuin-A (FetA) (Pal et al., 2012). In mice 
adipocytes, FetA as well as TLR4 knockdown prevents NEFA-
induced cytokines production and NF-κB activation. In addition, 
absence of FetA blocks NEFA-induced IL-6 upregulation in RAW 
264.7 macrophages. In the TLR4 protein, site-directed mutagenesis 
revealed that LRR2 and LRR6 are essential for the binding with the 
NEFA-FetA complex. FetA appears to be the equivalent of LBP for 
LPS. As LBP, FetA is produced by the liver and acts as an 
endogenous presenter of NEFA to TLR4.  
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2.1.4. Regulation of endoplasmic reticulum stress by toll-like 
receptor 4 
Host defense against pathogen invasion activates several stress 
pathways to orchestrate adaptive response. It appears that TLR4 
engagement disrupts ER homeostasis. LPS induced ER stress in 
different cell types and tissues including lung, liver, adipocytes, 
human B cells, THP-1 cells and intestinal cells (Endo et al., 2006, 
Kuribayashi et al., 2008, Kozlov et al., 2009, Coope et al., 2012, 
Afrazi et al., 2014, Alhusaini et al., 2010). To the best of our 
knowledge, such experiments have not been carried out in skeletal 
muscle.  
The mechanism by which TLR4 mediates ER stress is still 
unknown, but probably arises from an increase of ER protein load. In 
the ER, a greater flux of nascent protein could create an imbalance 
between protein load and folding capacity leading to ER stress. In 
skeletal muscle as well as immune cells, TLR4 signaling cascade 
culminates with the production of a large amount of secreted and 
membrane proteins including cytokines and TLR4 receptor. In C2C12 
myotubes, palmitate and LPS induced a large production of IL-6 in 
C2C12 (Frost et al., 2006, Jove et al., 2005). TLR4 expression 
increases in human myotubes incubated with palmitate or lipid A 
(Reyna et al., 2008). 
Furthermore, TLR4-dependent cytokines could indirectly disrupt 
ER homeostasis. TNFα and IL-1β induced ER stress in L929 cells and 
liver respectively (Xue et al., 2005, Zhang et al., 2006).  
Finally, TLR4 activation could disrupt the folding capacity. It is 
well established that LPS stimulation is associated with oxidative 
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stress. In mice injected with LPS, oxidative stress has been detected in 
skeletal muscle as shown by TBARS assay and GSH/GSSG ratio 
(Cruzat et al., 2014). In the next part, we will discuss the mechanism 
by which oxidative stress could induce ER stress. 
 
2.2. Oxidative stress and endoplasmic reticulum stress in muscle 
cells 
 
2.2.1. Hydrogen peroxide homeostasis 
About 2.8 billion years ago, cyanobacteria start to modify 
atmosphere composition. Thanks to their photosynthetic process, they 
had converted carbon dioxide into dioxygen leading to a turning point 
of the evolution. The rise of dioxygen concentration forced life to 
adapt biochemical processes. Most aerobic organisms used oxygen as 
a final electron acceptor in a complex chain reaction coupled with 
energy production. Paradoxically, dioxygen consumption is 
accompanied by the production of toxic molecules which are involved 
in most human disorders.  
 
 
 
 
 
 
 
 
Potential mechanisms of lipid-induced endoplasmic reticulum stress 29 
 
 
Dioxygen possesses an unusual electron configuration. Ground 
state dioxygen contains two unpaired electrons with parallel spins, it is 
a triplet diradical species. To fill its valence shell, dioxygen tends to 
attract electrons, producing thereby radical species. In other words, 
dioxygen is an oxidizing agent. In eukaryotic cells, sequential 
univalent reduction of dioxygen produces molecules known as 
reactive oxygen species (ROS) (Figure 2.4). 
 
 
Figure 2.4. Successive monovalent reduction of dioxygen 
 
Among ROS, hydrogen peroxide appears a key molecule in cell 
physiology and pathology. Because of its relative long half-life and 
high diffusion capacity, hydrogen peroxide passes through the 
membrane and, it is recognized as a signaling molecule regulating 
many physiological processes such as immune response, apoptosis, 
mitochondria biogenesis, autophagy and differentiation (Powers et al., 
2010, Barbieri and Sestili, 2012). On the other hand, univalent 
reduction of hydrogen peroxide produces hydroxyl radical, the most 
aggressive ROS (Barbieri and Sestili, 2012). Hydrogen peroxide 
concentration is tightly regulated by a balance between production and 
clearance.  
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The scavenging of hydrogen peroxide depends mainly on 
glutathione peroxidase (GPx), GSH level and to a lesser extent 
catalase (Csordas and Hajnoczky, 2009). On the opposite, superoxide 
dismutation is the principal source of hydrogen peroxide, a reaction 
catalyzed by the superoxide dismutase (SOD) (Figure 2.5). 
 
 
Figure 2.5. Scavenging of hydrogen peroxide by catalase and GPx 
 
Skeletal muscle is particularly exposed to ROS. Indeed, aerobic 
contraction increases superoxide production due to high oxygen 
consumption. In muscle cells, superoxide is produced by: 1) 
mitochondria; 2) nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase (NOX); 3) phospholipase A2 (PLA2); 4) xanthine 
oxidase (XO). 
 
In the mitochondria, electrons from NADH and FADH2 are 
transferred from electron donor to electron acceptor molecules in a 
process coupled with energy production. Electrons are transported 
through four enzymatic complexes known as electrons transport chain. 
In the cytochrome c oxidase or complex IV, dioxygen undergoes 
tetravalent reduction to produce water. However, some electrons leak 
before reaching complex IV, this occurs mainly at complex I and III 
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(Powers and Jackson, 2008). Free electrons are transferred to 
dioxygen to produce superoxide. In skeletal muscle, it has been 
reported that ~0.15% of dioxygen consumed by mitochondria give rise 
to hydrogen peroxide, this result remains controversial and probably 
depends on fiber types and oxidized substrates (Barbieri and Sestili, 
2012, St-Pierre et al., 2002).  
 
The enzymatic complex NOX transfers electron from NADPH to 
dioxygen to produce superoxide. Immune cells such as neutrophils 
and macrophages highly express the phagocyte NADPH oxidase now 
called NOX2. In these cells, NOX2 is used as a «superoxide gun» to 
kill pathogen during phagocytosis (Csordas and Hajnoczky, 2009). 
Recently, six non-phagocytic NOXs have been found: NOX1, NOX3, 
NOX4, NOX5, DUOX1 and DUOX2 (Kleniewska et al., 2012). 
Skeletal muscle expressed both NOX2 and NOX4 located in the 
sarcoplasmic reticulum, the sarcolemma and transverse tubules 
(Cheng et al., 2001, Powers and Jackson, 2008). It has been reported 
that NOX4 is constitutively active and produced directly hydrogen 
peroxide (Nisimoto et al., 2010). In skeletal muscle, NOX clearly 
contributes to ROS production at rest and during exercise (Powers and 
Jackson, 2008). However, the physiological function of NOXs in 
muscle cells remains poorly understood. 
 
PLA2 hydrolyses membrane phospholipid and releases arachidonic 
acid. This NEFA is a substrate for the lipoxygenases, which reduce 
dioxygen to produce superoxide. Furthermore, PLA2 could stimulate 
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NOXs and mitochondria superoxide production (Barbieri and Sestili, 
2012). 
 
 XO catalyzed the oxidation of hypoxanthine and xanthine to 
produce xanthine and acid uric, respectively. In these reactions, 
dioxygen is converted into superoxide. XO contributes to superoxide 
production in skeletal muscle of rat (Gomez-Cabrera et al., 2005). In 
human skeletal muscle, generation of superoxide by XO is unclear due 
to the low expression of this enzyme (Powers and Jackson, 2008). 
 
Finally, ER produces directly hydrogen peroxide during disulfide 
bond formation (chapter 1).  
 
2.2.2. Induction of oxidative stress by lipids 
Oxidative stress results from imbalance between the level of 
oxidative and antioxidant molecules. In muscle cells, measures of 
ROS production and oxidative damage demonstrated that lipid excess 
induced oxidative stress in vitro, ex vivo and in vivo. In L6 myotubes, 
palmitate increased mitochondrial ROS production in a dose-
dependent manner (Yuzefovych et al., 2010). In soleus and extensor 
digitorum longus from rat, palmitate induced ROS production through 
mitochondria and NOXs but not XO (Lambertucci et al., 2008). 
Anderson et al. (2009) shown that mitochondrial hydrogen peroxide 
emission increases in gastrocnemius from rats fed with HFD 
(Anderson et al., 2009). In a similar model, it has been reported that 
muscle protein carbonyl content, a marker of oxidative protein 
damage, increases with HFD (Paglialunga et al., 2012). In human fed 
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with a high-fat meal, mitochondrial hydrogen peroxide production 
increases in the vastus lateralis from lean and obese subjects 
(Anderson et al., 2009). In addition, the lipid peroxidation content of 
vastus lateralis, a marker of lipid oxidative damage, was 3-fold higher 
in obese than lean subjects (Russell et al., 2003).  
 
In vitro studies revealed that only saturated NEFA induces ROS 
production in muscle cells. ROS levels increased in L6 myotubes 
exposed to palmitate but not palmitoleate (C16:1) (Pillon et al., 2012). 
In addition, oleate (C18:1) did not change mitochondrial ROS 
production in L6 myotubes (Yuzefovych et al., 2010). Lipid excess is 
either stored as triglycerides (TG) or converted into lipid-derived toxic 
metabolites such as diacylglycerides (DAG) and ceramides. The latter 
appears a good candidate linking saturated NEFA to ROS production. 
Ceramides constist of sphingosine amine linked to NEFA. 
Importantly, ceramide content increases in skeletal muscle from obese 
subjects and HFD-fed rats (Adams et al., 2004, Zendzian-Piotrowska 
et al., 2006). As ROS production, ceramide synthesis seems 
specifically stimulated by saturated NEFA. In C2C12 myotubes as 
well as human myoblast, palmitate but not oleate increases ceramide 
levels (Pickersgill et al., 2007, Chavez et al., 2003). Similar results 
were found in L6 myotubes (Lee et al., 2006). The effect of palmitate 
on ROS production seems largely mediated by ceramides. C2-
ceramide, an analogue of ceramides, increases dose-dependently 
mitochondrial ROS production in L6 myotubes (Yuzefovych et al., 
2010). In the same study, the authors showed that palmitate-induced 
mitochondrial ROS accumulation is blocked by fumonisin B1, an 
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inhibitor of de novo ceramide synthesis. All together, these results 
indicated that saturated NEFA, ceramides and ROS production are 
closely associated in skeletal muscle. 
 
2.2.3. Oxidative stress and endoplasmic reticulum stress: a vicious 
circle  
The used of antioxidant strategies highlighted the cross-talk 
between oxidative stress and ER stress in different cell types. In L929 
fibroblast cells, TNFα induced ER stress in a ROS-dependent manner 
(Xue et al., 2005). TNFα as well as tunicamycin activated the PERK 
and IRE1 pathway as shown by the increase of phospho-eIF2α and 
XBP1s mRNA, respectively. These effects were completely prevented 
by butylated hydroxyanisole, an antioxidant molecule. Furthermore, 
dilatation of ER induced by TNFα and tunicamycin was inhibited by 
butylated hydroxyanisole. In H9c2 rat cardiomyoblasts, the 
antioxidant α-tocopherol partially prevents the upregulation of BiP 
and CHOP protein induced by palmitate exposure (Borradaile et al., 
2006). The link between oxidative stress and ER stress is supported in 
other cell types including murine mesencephalic cells (MN9D), 
human retinal pigment epithelium (RPE) cells and HeLa cells (Holtz 
et al., 2006, He et al., 2008, Pallepati and Averill-Bates, 2011). Other 
report suggested that oxidative stress is uncoupled from ER stress. In 
endothelial cells, the antioxidants α-tocopherol and ascorbic acids 
inhibited ROS generation but not ER stress induced by glucotoxicity 
(Sheikh-Ali et al., 2010). The relation between oxidative stress and 
ER stress seems cell types-dependent. 
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In vivo, oxidative stress was induced in mice by adding buthionine 
sulfoximine, a GSH synthase inhibitor, in drinking water (Guo et al., 
2009). After two weeks, ER stress was detected in cardiac muscle as 
shown by the increase of BiP, phospho-eIF2α, calreticulin and 
phospho-IRE1α. These effects were abolished in mice with cardiac-
specific overexpression of the antioxidant metallothionein (Guo et al., 
2009). Although skeletal muscle produces a large amount of ROS, the 
effect of oxidative stress on ER homeostasis has not been investigated 
in this organ. 
 
The mechanism by which oxidative stress promotes ER stress is 
still under investigation. Recently, studies suggested that proximity 
between ER and mitochondria enables local communication. More 
precisely, ROS from mitochondria targets ER-based calcium channels 
leading to leak of calcium from ER. The increase of cytosolic calcium 
stimulates mitochondria metabolism to produce more ROS, resulting 
in a vicious circle (Malhotra and Kaufman, 2007b). As noted in 
chapter 1, calcium concentration tightly regulates ER protein folding.  
In different cell types, the gap between ER and mitochondria did 
not exceed 50 nm (Csordas and Hajnoczky, 2009). Mitochondria 
appears partially engulfed by ER network as shown by electron 
microscopy (Mannella, 2000). Cell fractionation demonstrated 
physical contact between ER and mitochondria. In 1990, Vance found 
that mitochondria copurifies with some part of the ER in differential 
centrifugation, this fraction was originally called: «fraction X» 
(Vance, 1990). Membrane contact site between ER and mitochondria 
now referred to mitochondria-associated ER membrane (MAM). This 
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space enables mouth-to-mouth exchange of multiple molecules 
including calcium and ROS.  
ROS from mitochondria can rapidly interact with ER 
transmembrane protein such as calcium channels. Oxidation of 
calcium channel in specific Cys thiol group highly regulates their 
activity (Csordas and Hajnoczky, 2009). ROS increases the activity of 
RyR1, the calcium release channel essential for excitation-contraction 
coupling in skeletal muscle (Lanner et al., 2010). In rabbit skeletal 
muscle, catalase reduced RyR1 activity in a dose-dependent manner 
(Sun et al., 2011). In C2C12 myotubes, inhibition of NOX4 by siRNA 
or pharmacological agent abolished RyR1 activity induced by 
NADPH and high pO2 (Sun et al., 2011). Calcium flux measurement 
confirmed these results. Similarly, in cardiac muscle, oxidation of 
certain thiol groups resulted in irreversible activation of the ryanodine 
receptor (Xu et al., 1998). Regulation of RyR1 by ROS seems 
dependent on their concentration. In skeletal muscle from rabbit, 
hydrogen peroxide up to 10 mM stimulates dose-dependently RyR1 
activity while 100 mM totally inhibits the calcium release channel 
(Favero et al., 1995). Oxidative stress also targets SERCA pumps, 
IP3Rs and their regulatory partner. Full details are presented in the 
review by Csordás and Hajnóczky (Csordas and Hajnoczky, 2009).  
 
2.3. Membrane lipid composition and endoplasmic reticulum 
stress 
Cells membranes have been modeled as a “fluid mosaic”, where 
the phospholipid (PL) bilayer and the anchored proteins represent the 
fluid and mosaic tiles, respectively (Singer and Nicolson, 1972). 
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Motions of these proteins depend on the membrane fluidity, i.e., the 
intermolecular attractive forces of the fluid. This mechanical property 
is influenced, among others, by the type of NEFA incorporated into 
PL. More precisely, saturation and length of these NEFA are inversely 
related to membrane fluidity. Modifications in membrane property are 
involved in physiological and pathological processes. Indeed, the 
functioning of membrane-bound proteins is highly regulated by 
membrane fluidity (Lenaz, 1987). Recently, it has appeared that 
changes in the composition of ER membrane lipids could be another 
mechanism by which NEFA disrupts ER homeostasis. Evidences of 
such a regulation have been demonstrated thanks to manipulation of 
the stearoyl-CoA-desaturases (SCD). These enzymes are crucial to the 
biosynthesis of oleate and the formation of unsaturated membrane PL 
(Lyn et al., 2014). In Caenorhabditis elegans, SCD depletion 
increased BiP expression. This effect was reversed by oleate 
supplementation (Hou et al., 2014). Similar results were found in 
293T cells (Volmer et al., 2013). In addition, PERK activity increased 
with PL saturation in proteoliposomes (Volmer et al., 2013). This 
suggests an alternative mechanism by which lipids, particularly 
saturated NEFA, could disrupt ER homeostasis. Such a mechanism 
could be physiologically relevant given that dietary lipid intake 
regulates membrane composition (Abbott et al., 2012). 
However, this mechanism seems independent of proteostasis-
imbalance. Indeed, SCD depletion did not induce protein aggregation 
(Hou et al., 2014). Furthermore, deletion of the luminal unfolded 
protein stress-sensing domain of IRE1α and PERK prevented their 
activation by thapsigargin but not by membrane lipid saturation 
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(Volmer et al., 2013). In Caenorhabditis elegans, ~90% of the UPR-
inducible genes are not regulated through modification of membrane 
lipid composition, showing thereby an incomplete UPR. Collectively, 
these results highlight a new type of ER stress and UPR, which are not 
related to proteostasis. In order to avoid confusion, activation of the 
ER stress response induced by membrane lipid saturation should bear 
another name than UPR. 
 
In conclusion, ER is sensitive to various stressful environments 
including those caused by ROS, innate immune system engagement 
and changes in membrane lipid content. In this setting, oxidative 
stress, TLR4 activation and membrane lipid saturation appear as 
potential mechanisms of NEFA-induced ER stress. 
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Chapter 3: Mechanisms of lipid-induced insulin 
resistance in muscle cells 
 
3.1. Regulation of glucose uptake by insulin 
Insulin is the master regulator of glycaemia in post-prandial state. 
After a meal, increase of glycaemia stimulates insulin secretion by the 
pancreatic β-cells. Insulin promotes glucose uptake mainly in organs 
widely expressing the insulin sensitive glucose transporter 4 
(GLUT4), i.e., skeletal muscle, adipose tissue and cardiac muscle. 
Insulin action is mediated by several effectors and culminates with the 
translocation of GLUT4 to the membrane, allowing thereby the entry 
of glucose into the cell (Figure 3.1). 
Insulin binds to its transmembrane receptor, the insulin receptor 
(IR). IR is a heterotetramer composed by two extracellular α subunits 
and two transmembrane β subunits linked to each other by disulfide 
bridges (Chang et al., 2004). Insulin interaction with the α subunits 
activates the tyrosine kinase domain of the β subunits, resulting in 
autophosphorylation of several tyrosine residues located in the 
juxtamembrane region and intracellular C-tail (White and Kahn, 
1994). Tyr960 of IR is a key residue for the regulation of insulin-
stimulated glucose transport (White and Kahn, 1994). This docking 
site recruits proteins which contain a phosphotyrosine binding (PTB) 
domain. Among these proteins, the insulin receptor substrates 1 and 2 
(IRS-1 and IRS-2) mediate most of the insulin effects. IRS-1/2 
contains a PTB domain next to a pleckstrin homology (PH) domain 
(White, 2003). Due to its high affinity for phospholipids, the PH 
domain of IRS1/2 stabilizes the protein at the membrane and 
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facilitates the phosphorylation of its PTB domain by IR. 
Phosphorylated IRS1/2 on tyrosine residue recruits the regulating 
subunit (p85) of phosphatidyl inositol 3-kinase (PI3K) through its Src 
homology 2 (SH2) domains. This interaction leads to the activation of 
PI3K catalytic subunit (p110), which catalyzes the formation of the 
membrane phospholipid phosphatidylinositol 3,4,5-trisphosphate 
(PIP3) from phosphatidylinositol 4,5-diphosphate (PIP2) (Chang et al., 
2004). PIP3 recruits Akt (also known as protein kinase B) and 
phosphoinositide-dependent kinase-1 (PDK1) to the membrane 
through their PH domains.  
The serine/threonine kinase Akt contains a PH domain in its N-
terminal end, a kinase domain and a C-terminal hydrophobic domain. 
In mammalian, three isoforms of Akt have been identified: Akt1, Akt2 
and Akt3. Akt1 is widely expressed, whereas Akt3 is principally 
found in brain and testes. Akt2 expression is predominant in 
adipocytes and myocytes, where it is responsible of glucose uptake 
(Hers et al., 2011). In the cytosol, Akt is maintained in an inactive 
state through an association between its kinase and PH domains. 
When recruited to the membrane by PIP3, Akt is phosphorylated by 
PDK1 and mammalian target of rapamycin complex 2 (mTORC2) on 
Thr308 (kinase domain) and Ser473 (C-terminal domain), respectively. 
Akt activity increases by 100-fold when phosphorylated on Thr308, but 
full activation requires Ser473 phosphorylation (Hers et al., 2011). 
Activated Akt returns to the cytosol and phosphorylates the TBC1 
family member 1 (TBC1D1) and 4 (TBC1D4, formerly known as Akt 
substrate 160, AS160). TBC1D1/TBC1D4 proteins have GTPase 
activity toward several Rab proteins (G proteins) associated with 
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GLUT4 storage vesicles (GSVs). This GTPase activity is inhibited by 
Akt phosphorylation, leading to an increase of the active forms of 
Rab, i.e., Rab GTP-bound form (Sakamoto and Holman, 2008). 
Activated Rab promotes all the steps of GLUT4 exocytosis: approach, 
tethering, docking and fusion (Stockli et al., 2011). In muscle cells, it 
seems that Rab8A-Rab13 and Rab14 are under the control of TBC1D4 
and TBC1D1, respectively (Klip et al., 2014). Activated Rab8A 
associated with the myosin Va, a processive motor which promotes 
GSVs displacement on actin filaments. It seems that Rab13 regulates 
the tethering of GSVs to the plasma membrane. In skeletal muscle, the 
role of Rab14 is still unknown. More generally, identification, 
regulation and individual functions of theses insulin-sensitive Rab 
proteins remain elusive (Klip et al., 2014).  
Recently, actin reorganization has appeared as an essential step of 
GLUT4 traffic. Independently of Akt downstream signaling, insulin 
regulates cytoskeletal remodeling through Rac1, another G protein 
(Chiu et al., 2011). Upon insulin stimulation, PI3K phosphorylation 
leads to Rac1 GTP loading by a not yet defined mechanism (Klip et 
al., 2014). Activated Rac1 induces branching of the cortical actin.  
Actin dynamics regulation seems to promote the tethering of GSVs 
and insulin effectors to the plasma membrane (Chiu et al., 2011). 
 
The scientific knowledge described in this paragraph is highly 
dynamic and not homogenous. The signaling from IR to Akt has been 
well established, whereas regulation of GLUT4 exocytosis by Akt-
dependent and -independent mechanisms is less understood and 
required further explorations. 
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Figure 3.1. Regulation of glucose uptake by insulin. See details in the text. 
 
3.2. Inhibition of insulin-stimulated glucose uptake by lipids: the 
never ending story 
Insulin resistance is generally defined as a reduced ability of insulin 
to stimulate glucose uptake and to inhibit hepatic glucose production. 
This pathologic state is associated with obesity and metabolic 
syndrome. Obesity is characterized by an excess of energy stored as 
lipids in adipocytes, but also in ectopic tissues such as liver and 
skeletal muscle. In addition to intracellular deposits, fat accumulates 
in blood (e.g., NEFA, triglycerides, ceramides and cholesterol). The 
causal relationship between fat accumulation and insulin resistance is 
now well established.  
In a famous paper published in The Lancet, Randle et al. (1963) 
were the first to propose that lipids inhibit glucose metabolism, a 
mechanism known as glucose-fatty acid cycle or Randle cycle (Randle 
et al., 1963). According to the authors, lipid oxidation alters glucose 
utilization and conversely. At first sight, it is a happy ending story. 
Competition between lipids and glucose for oxidation adapts the 
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energetic substrates to diet composition, regulating thereby lipids and 
glucose homeostasis. However, Randle et al. (1963) already pointed 
out that glucose-fatty acid cycle could participate in glucose 
metabolism disorder such as insulin resistance (Randle et al., 1963).  
Fifty-years later, much progress have been done, and we learned 
that insulin resistance physiopathology differs between liver, muscle 
and adipose tissue. Herein, we will focus on lipid-induced insulin 
resistance in skeletal muscle. In human, skeletal muscle accounts for 
~80% of insulin-mediated glucose uptake (DeFronzo et al., 1981). 
This indicates that hyperglycemia, the hallmark of type 2 diabetes, 
strongly depends on the capacity of skeletal muscle to remove glucose 
from the circulation. 
 
According to the mechanism proposed by Randle, lipid excess 
increases acetyl-CoA and citrate concentrations, resulting in the 
inhibition of pyruvate dehydrogenase (PDH) and phosphofructokinase 
1, respectively (Randle, 1998). Then, accumulation of glucose-6-
phosphate inhibits hexokinase II and subsequently decreases glucose 
uptake. This hypothesis was not confirmed in skeletal muscle. In 
human submitted to an euglycemic-hyperinsulinemic clamp, 
lipid/heparin infusion inhibited glucose oxidation but failed to 
increase citrate concentration and to inhibit PDH activity in muscle 
biopsies (Boden et al., 1991, Saloranta et al., 1993). Another argument 
against the Randle hypothesis came from Roden et al. (1996) and 
(1999). They used 31P NMR spectroscopy to continuously monitor 
gastrocnemius glucose-6-phosphate concentration in healthy 
volunteers during euglycemic-hyperinsulinemic clamp (Roden et al., 
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1996, Roden et al., 1999). Lipid infusion increased time-dependently 
plasma NEFA concentrations and drastically reduced whole-body 
glucose disposal. In contrast to the Randle hypothesis, glucose-6-
phosphate decreased rapidly after lipid infusion. Similar results were 
found in type 2 diabetic subjects (Rothman et al., 1995). Collectively, 
these results clearly indicated that the Randle hypothesis does not 
apply to skeletal muscle. However, it does not totally exclude a direct 
effect of lipids on glucose metabolism. Indeed, lipids could inhibit 
hexokinase II, causing a decrease of glucose-6-phosphate and an 
increase of glucose concentration. To test this hypothesis, Dresner et 
al. (1999) measured intracellular glucose by 13C NMR spectroscopy in 
muscle biopsies of healthy volunteers submitted to euglycemic-
hyperinsulinemic clamp (Dresner et al., 1999). In this study, lipid 
infusion reduced intracellular glucose, suggesting that hexokinase II 
was not inhibited. This indicates that lipids inhibit glucose transport 
rather than glucose metabolism in skeletal muscle. Inhibition of 
glucose oxidation and glycogen synthesis by lipids is probably a 
consequence of a primary defect in glucose transport. It is now well 
accepted that lipids impair GLUT4 translocation, mainly due to an 
inhibition of insulin signaling.  
Extracellular lipids can disrupt insulin signaling through TLR4, this 
will be discussed in chapter 8. Furthermore, intracellular lipids are 
also associated with insulin resistance. In this setting, the case of TG, 
DAG and ceramides in skeletal muscle will be discussed herein. 
 
Intramyocellular triglycerides (IMTG) concentrations do not seem 
associated with insulin sensitivity as shown by the “athlete's paradox”. 
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Endurance-trained athletes are considered highly sensitive to insulin, 
despite an increase of IMTG levels to the same extent of obese and 
insulin-resistant subjects (Russell et al., 2003). Although IMTG 
concentration does not seem a key factor, their peroxidation deserves 
a particular attention. In the vastus lateralis, IMTG peroxidation 
levels are 6-fold higher in obese subjects than in endurance-trained 
athletes (Russell et al., 2003). However, a relationship with insulin 
resistance remains hypothetical.  
 
In vitro experiments demonstrated that saturated NEFA, unlike 
unsaturated NEFA impairs insulin signaling in C2C12 and L6 
myotubes (Yuzefovych et al., 2010, Coll et al., 2008, Peng et al., 
2011). The effect of saturated NEFA on insulin pathway seems 
partially mediated by lipid-derived toxic metabolites such as DAG and 
ceramides. 
 
The effect of DAG on insulin signaling could be mediated by the 
novel protein kinase C theta (PKCθ), the most abundant isoform of 
PKC in muscle cells (Li et al., 2004). DAG is well known to activate 
(PKCθ), which in turn phosphorylates IRS-1 on an inhibitory serine 
residue (Ser1011) (Li et al., 2004). Alternatively, PKCθ could act on 
IKK and JNK as it has been found in T-cells (Altman et al., 2000). 
Both of these kinases phosphorylate IRS-1 on an inhibitory serine 
residue, Ser307 in rodent and Ser312 in human (Morino et al., 2006). 
Interestingly, HFD increased PKCs activation as well as DAG content 
in skeletal muscle from rats (Schmitz-Peiffer et al., 1997). In 
euglycemic-hyperinsulinemic clamp experiment, PKCθ knockout 
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mice were protected against lipid-induced insulin resistance in skeletal 
muscle (Kim et al., 2004). However, mice with muscle-specific 
expression of a dominant-negative PKCθ are obese and insulin-
resistant (Serra et al., 2003). Consequently, the involvement of PKCθ 
in lipid-induced insulin resistance seems controversial. 
The implication of DAG in insulin resistance remains unclear in 
muscle cells. In C2C12 myotubes, palmitate increased DAG content 
by 6-fold and disrupted insulin signaling. However, inhibition of 
ceramide synthesis restored insulin signal but had no effect on DAG 
concentration (Chavez et al., 2003). Consequently, in this study high 
DAG level were not associated with insulin resistance. In addition, 
DAG content in skeletal muscle is higher in endurance-trained athletes 
than obese subjects (Amati et al., 2011). Unexpectedly, DAG 
concentration was increased in tibialis anterior of rats overexpressing 
the acylCoA:diacylglycerol acyltransferase-1 (DGAT1), an enzyme 
that catalyzes the formation of TG from DAG (Timmers et al., 2011). 
Upon HFD, the insulin-dependent glucose uptake in tibialis anterior 
was higher in those rats compared to control rats. All together, these 
results demonstrate a disconnection between DAG content and insulin 
sensitivity in skeletal muscle. However, the biological effects of DAG 
depend on their composition, i.e., the length and saturation of the fatty 
acid chains. Further studies are needed to evaluate the contribution of 
each DAG species to skeletal muscle insulin resistance. Indeed, if 
DAG mediates insulin resistance in skeletal muscle, the underlying 
mechanism is unresolved.  
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Ceramides are important mediators of lipid-induced insulin 
resistance in skeletal muscle. Contrary to DAG and IMTG, the 
“athlete's paradox” does not applies to ceramides. In skeletal muscle, 
ceramide content is higher in obese than lean sedentary and 
endurance-trained athletes (Amati et al., 2011). In C2C12 myotubes, 
palmitate as well as ceramides prevented insulin-stimulated Akt 
phosphorylation (Chavez et al., 2003, Hage Hassan et al., 2012). On 
the other hand, the inhibitory effect of palmitate on Akt was restored 
by the inhibition of de novo ceramide synthesis. Importantly, similar 
results were found with three different inhibitors. Those molecules 
were myriocin and cycloserine, which inhibit serine 
palmitoyltransferase (SPT), and fumonisin B1 (FB1) which acts on 
ceramide synthase (Chavez et al., 2003, Hage Hassan et al., 2012).  
At a signaling level, ceramides are well known to inhibit Akt 
through the protein phosphatase 2A (PP2A) and the atypical PKCζ 
(Martins et al., 2012). It seems that PKCζ did not impair Akt 
phosphorylation in muscle cells (Cazzolli et al., 2001). In C2C12 
myotubes, inhibition of PP2A with okadaic acid or the SV40 small 
antigen prevented the inhibitory effect of palmitate on insulin-
stimulated Akt phosphorylation (Chavez et al., 2003, Cazzolli et al., 
2001). However, in L6 myotubes, okadaic acid failed to restore a loss 
of Akt phosphorylation and activity induced by ceramides (Hajduch et 
al., 2001). The role of ceramides in lipid-induced insulin resistance 
has been assessed in vivo by injection of myriocin in HFD-fed and 
db/db mice (Ussher et al., 2010). In both models, myriocin prevented 
insulin resistance. However, myriocin increased also energy 
expenditure. Consequently, it was not clear whether myriocin acted 
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through ceramides synthesis and/or energetic metabolism. Although 
ceramides clearly alter insulin signaling in vitro, the lack of in vivo 
experiments does not allow strong conclusions. 
Alternatively, ceramides could induce insulin resistance via 
oxidative stress. Indeed, ceramides increase ROS production (chapter 
2), and oxidative stress is well known to disrupt insulin signaling in 
skeletal muscle (Martins et al., 2012). However, this is beyond the 
scope of this thesis. 
 
3.3. Inhibition of insulin pathway by endoplasmic reticulum stress 
In the last decade, ER stress appeared as a key actor in the 
development of insulin resistance. ER stress has been reported in liver 
and adipose tissue from leptin deficient (ob/ob) mice and HFD-fed 
mice (Ozcan et al., 2004). In human, ER stress has been related to 
body weight (Gregor et al., 2009). Markers of ER stress were 
measured before and one year after gastric bypass surgery in morbidly 
obese subjects. After 39% weight loss, phospho-eIF2α, XBP1s and 
BiP mRNA were reduced in adipose tissue, whereas 
immunochemistry showed that phospho-eIF2α and BiP levels were 
decreased in liver. Interestingly, whole-body insulin sensitivity was 
drastically increased by gastric bypass surgery as shown by the 
reduction (70%) of the HOMA-IR.  
 
Ozcan et al. (2004) were the first to causally link ER stress to 
insulin resistance (Ozcan et al., 2004). In Fao liver cells, they showed 
that ER stress induced by tunycamicin inhibited insulin signaling at 
the level of IRS-1 and Akt. In vivo, deletion of an XBP1 allele in mice 
Mechanisms of lipid-induced insulin resistance in muscle cells 49 
 
 
was used to induce ER stress. After 16-weeks HFD, XBP1-/+ mice 
became more insulin-resistant than WT mice as shown by oral glucose 
tolerance test (OGTT) and insulin tolerance test (ITT) (Ozcan et al., 
2004). In the following study, Ozcan et al. (2006) prevented liver ER 
stress in ob/ob mice by oral administration of the chemical chaperones 
tauroursodeoxycholic acid (TUDCA) or 4-phenyl butyric acid (PBA) 
(Ozcan et al., 2006). Upon TUDCA or PBA administrations, ob/ob 
mice did not developed whole-body insulin resistance. To determine 
the contribution of each organ, Ozcan et al. (2006) performed 
euglycemic-hyperinsulinemic clamps. They showed that liver, adipose 
tissue and skeletal muscle were protected against insulin resistance. 
In the paper from Ozcan et al. (2004), ER stress was measured in 
liver and adipose tissue (Ozcan et al., 2004). They indicated in 
unpublished observations: “no indication for ER stress was evident in 
the muscle tissue of obese animals”. In 2006, they showed in ob/ob 
mice that TUDCA and PBA increased largely skeletal muscle glucose 
disposal during euglycemic-hyperinsulinemic clamp (Ozcan et al., 
2006). Thus, this suggests that ER stress is involved in the 
physiopathology of skeletal muscle insulin resistance. Later, studies 
from our lab as well as others have demonstrated the occurrence of ER 
stress in muscle cells exposed to high lipid concentration. In C2C12 
myotybes, 17 h palmitate (1 mM) incubation increased phospho-
PERK, BiP and IRE1α proteins as well as ATF4, CHOP and XBP1s 
mRNA levels (Deldicque et al., 2010). Similar results were reported in 
L6 myotubes and human primary myotubes (Hage Hassan et al., 2012, 
Peter et al., 2009, Peng et al., 2011). Furthermore, after HFD, ER 
stress was present in skeletal muscle of mice (Deldicque et al., 2010, 
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Rieusset et al., 2012). However, it seems that short-term HFD did not 
induce ER stress in human skeletal muscle. In healthy volunteers, 6-
weeks HFD diet failed to upregulate ER stress markers in the vastus 
lateralis (Deldicque et al., 2011b). 
 
In muscle cells, ER stress seems implicated in the development of 
insulin resistance. In C2C12 myotubes, tunicamycin blocked insulin-
dependent Akt phosphorylation and glucose uptake (Deldicque et al., 
2011a, Panzhinskiy et al., 2013). These deleterious effects were 
prevented by TUDCA (Panzhinskiy et al., 2013). Similar results were 
found with PBA in C2C12 myoblast (Peng et al., 2011). However, 
these findings seem inconsistent with two other reports. In C2C12 
myotubes, BiP overexpression as well as TUDCA or PBA treatment 
did not protect against palmitate-induced insulin resistance (Hage 
Hassan et al., 2012, Rieusset et al., 2012). Collectively, this suggests 
that only supraphysiological ER stress could induce insulin resistance 
in muscle cells.  
 
At a mechanistic level, connections have been reported between 
UPR and mediators of insulin resistance: JNK/IKK and the tribbles 
homolog 3 (TRB3). The Figure 3.2 exhibits the potential connections 
between UPR and insulin signaling. 
IRE1α is known to activate JNK and IKK through the adapter 
protein TRAF2. Both of these kinases phosphorylate IRS-1 on an 
inhibitory serine residue. IRE1α-/- fibroblasts were protected against 
JNK activation and IRS-1 serine phosphorylation induced by 
tunicamycin (Ozcan et al., 2004). In a breast cancer cell line (MCF-7), 
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IRE1α knockdown prevented IKK activation induced by tunicamycin 
or thapsigargin (Hu et al., 2006). Similar results were found in 
fibroblasts (Hu et al., 2006). However, no study investigated whether 
JNK and IKK are activated by IRE1α in muscle cells. In addition, 
these mechanisms have been demonstrated only with chemical ER 
stress inducers. 
Recently, TRB3 emerged as a candidate for ER stress-induced 
insulin resistance. Under ER stress, ATF4 and CHOP cooperate to 
upregulate TRB3 (Ohoka et al., 2005). Studies demonstrated that 
TRB3 prevents Akt phosphorylation. TRB3 possesses a kinase-like 
domain, but lack the ATP binding site and the consensus motif of the 
catalytic core domain H/Y R D L K/R X X N (Mayumi-Matsuda et 
al., 1999). Therefore, TRB3 belongs to the pseudokinase family. It has 
been showed that TRB3 inhibits insulin-stimulated Akt 
phosphorylation in the liver (Du et al., 2003). In this study, the authors 
demonstrated that TRB3 binds preferentially with the 
unphosphorylated kinase domain of Akt. Later, an interaction between 
TRB3 and the PH domain of Akt has been reported (He et al., 2006). 
Furthermore, a higher TRB3 expression correlated with a decrease of 
Akt translocation to the membrane. This effect was restored by TRB3 
knockdown (He et al., 2006). Consequently, He et al. (2006) proposed 
that TRB3 sequesters Akt in the cytosol, preventing thereby its 
migration to the membrane and subsequent activation. However, 
interaction of TRB3 with Akt remains controversial. In hepatocytes, 
TRB3 overexpression did not inhibit insulin-dependent Akt 
phosphorylation (Iynedjian, 2005). 
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Interestingly, TRB3 seems involved in the physiopathology of 
insulin resistance. TRB3 knockout mice were less glucose intolerant 
than WT mice after a HFD (Koh et al., 2013). Furthermore, the 
expression of TRB3 in the skeletal muscle has been associated with 
insulin resistance. TRB3 protein expression is elevated in skeletal 
muscle from obese subjects, type 2 diabetic patients, leptin receptor 
deficient (db/db) mice, Zucker fatty rats and streptozotocin-induced 
diabetic rats (Liu et al., 2010, Koh et al., 2013). Altogether, these 
results seem to indicate that TRB3 could be implicated in the 
development of insulin resistance. Nevertheless, its role in lipid-
induced insulin resistance has not been evaluated in muscle cells. 
 
 
Figure 3.2. Potential connections between UPR and insulin signaling. See details 
in the text. 
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Chapter 4: Aim of the thesis 
Lipid excess is well known to cause ER stress in many organs 
including those regulating glucose homeostasis (Flamment et al., 
2012). However, the mechanism by which lipids disrupt ER 
homeostasis remains poorly understood. Interestingly, LPS, a ligand 
of TLR4 induced ER stress in different cell types (chapter 2). In 
addition to exogenous ligands, TLR4 recognizes endogenous 
molecules such as saturated NEFA. The fifth chapter will present a 
study designed to test whether TLR4 mediates lipid-induced ER stress 
in vivo. This experiment was carried out in WT and TLR4-/- mice 
submitted to chow or HFD. After HFD, ER stress was measured in 
skeletal muscle, liver and adipose tissue. In muscle cells, it is 
particularly unclear how metabolic factors influence ER functions 
(Hotamisligil, 2010). As noted in chapter 2, high concentrations in 
lipids is known to trigger oxidative stress, and the use of antioxidant 
molecules reduced ER stress induced by various conditions. Since 
muscle cells are great ROS providers, lipids could alter ER 
equilibrium due to oxidative stress. Chapter six aims to assess whether 
oxidative stress by itself induces ER stress in C2C12 myotubes.  
The inhibitory effect of lipids on glucose uptake is known for over 
fifty years (Randle et al., 1963), but the underlying mechanisms are 
not fully unraveled. Although UPR appears as a key mediator of lipid-
induced insulin resistance in hepatocytes and adipocytes, this 
mechanistic link remains controversial in muscle cells. Chapter seven 
will present a study design to evaluate the connections between UPR 
and insulin signaling in muscle cells.    
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Abstract 
The purpose of this study was to investigate whether toll-like receptor 
4 (TLR4) is implicated in the development of endoplasmic reticulum 
stress (ER stress) observed after a high-fat diet (HFD) in liver, skeletal 
muscle and adipose tissue. TLR4-/- and C57BL/6J wild-type mice 
(WT) were fed with chow or HFD (45% calories from fat) during 18 
weeks. An oral glucose tolerance-test was performed. The animals 
were sacrificed in a fasted state and the tissues were removed. TLR4 
deletion protected from body weight gain and glucose intolerance 
induced by HFD whereas energy intake was higher in transgenic mice 
suggesting larger energy expenditure. HFD induced an ER stress in 
skeletal muscle, liver and adipose tissue of WT mice as assessed by 
BiP, CHOP, spliced and unspliced XBP1 and phospho-eIF2α. TLR4-/- 
mice were protected against HFD-induced ER stress. Then, we 
investigated the main signaling downstream of TLR4 namely the NF-
κB pathway, expecting to identify the mechanism by which TLR4 is 
able to activate ER stress. The mRNA levels of cytokines regulated by 
NF-κB namely TNFα, IL-1β and IL-6, were not changed after HFD 
and phospho-IκB-α (ser 32) was not changed. Our results indicate that 
TLR4 is essential for the development of ER stress related to HFD. 
Nevertheless, the NFκ-B pathway does not seem to be directly 
implicated. The reduced fat storage in TLR4-/- mice could explain the 
absence of an ER stress after HFD. 
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Introduction 
Obesity is often associated with a chronic low grade inflammatory 
state (Greenberg and Obin, 2006, Wellen and Hotamisligil, 2005), 
which in turn contributes to the development of various metabolic 
diseases such as insulin resistance (Kim et al., 2004, Yuan et al., 2001, 
Hirosumi et al., 2002, Hotamisligil et al., 1996). During the last 
decade, major advances were made for identifying the molecular 
mechanisms leading to lipotoxicity in various cell types (Schaffer, 
2003). A high level of circulating non-esterified fatty acids (NEFA) is 
able to induce insulin resistance within a few hours in healthy 
volunteers suggesting that an alteration in intracellular lipid 
metabolism may impair insulin signaling (Roden et al., 1999, Roden 
et al., 1996). Ceramides and diacylglycerol (DAG) are lipid-derived 
toxic metabolites inhibiting insulin signal via dephosphorylation of 
protein kinase B (PKB) and phosphorylation of a serine residue on 
insulin receptor substrate (IRS) (Summers, 2006, Idris et al., 2001). 
However, one may not exclude that circulating NEFA per se are able 
to act on insulin sensitivity through binding to a membrane receptor 
and activating a downstream cascade of events that would crosstalk 
with insulin signaling. Indeed, previous observations suggest that 
circulating NEFA can bind a plasma membrane receptor, namely the 
toll-like receptor 4 (TLR4), and its co-receptors CD14 and MD-2 (Shi 
et al., 2006, Lee et al., 2001). 
The TLR are members of the pattern-recognition receptor family 
that play a key role in the innate immune system (Kaisho and Akira, 
2006). To date, thirteen mammalian TLR have been identified (Kaisho 
and Akira, 2006). TLR4, a subclass of TLR, is activated by the lipidic 
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domain of lipopolysaccharide (LPS), a gram-negative bacterial cell 
wall component (Miyake, 2004). Ablation of TLR4 in transgenic mice 
confers partial protection against insulin resistance induced by lipid 
infusion or high-fat diet (HFD) (Shi et al., 2006, Radin et al., 2008, 
Tsukumo et al., 2007, Kim et al., 2007, Davis et al., 2008, Poggi et al., 
2007). Therefore, TLR4 could be the missing link between high 
circulating lipids and insulin resistance. 
Lipid excess is known to cause another cell stress known as 
endoplasmic reticulum (ER) stress (Boden, 2009, Tsiotra and Tsigos, 
2006, Zhang and Kaufman, 2008, Deldicque et al., 2010) which is the 
consequence of a disequilibrium between the folding capacity of ER 
and the amount of proteins to be folded. To cope with this stress, the 
cell triggers a series of signal transduction known as the unfolded 
protein response (UPR), which is initiated at the level of three ER 
stress sensors: inositol-requiring 1α (IRE1α), double-stranded RNA-
dependent protein kinase (PKR)-like ER kinase (PERK) and 
activating transcription factor 6 (ATF6). Each of these sensors is 
associated with the protein chaperone immunoglobulin-heavy-chain-
binding protein (BiP). Upon accumulation of unfolded proteins in the 
ER lumen, BiP is released from PERK, IRE1α and ATF6 leading to 
their activation and downstream signaling. These pathways initiate a 
homeostatic response via: 1) protein synthesis inhibition through the 
phosphorylation of eukaryotic translation-initiation factor 2α (eIF2α); 
2) transcriptional up-regulation of genes involved in protein folding, 
transport and ER-associated protein degradation; 3) apoptosis 
mediated by C/EBP homologous (CHOP) (Zhang and Kaufman, 
2008). 
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ER stress was observed in liver of ob/ob and high-fat fed mice and 
was proposed to be involved in the pathophysiology of insulin 
resistance through an interaction between UPR and inflammation 
signaling (Ozcan et al., 2004). Indeed, a growing body of evidence 
suggests that UPR and insulin resistance are interconnected through at 
least 2 mechanisms: 1) IRE1α pathway induces c-Jun N-terminal 
kinase (JNK) phosphorylation which inhibits IRS; 2) PERK and 
IRE1α pathway activate transcription factors such as nuclear factor-
κB (NF-κB) and activator protein 1 (AP-1) which migrate to the 
nucleus and induce the transcription of cytokines known to contribute 
to the development of insulin resistance (Zhang and Kaufman, 2008, 
Urano et al., 2000, Ozcan et al., 2004). 
ER stress and TLR4 signaling are both major players in the 
development of insulin resistance induced by lipid excess. Whether 
those two actors act independently or are causally linked is still 
unknown. In the present study, we hypothesized that TLR4 signaling 
would mediate lipid-induced ER stress via activation of the NF-κB 
pathway. To test this hypothesis, TLR4 knockout (TLR4-/-) and wild-
type (WT) mice were fed with a HFD and the activation of ER stress 
in liver, skeletal muscle and adipose tissue was measured. Our results 
show that ER stress is activated by a HFD in WT whereas it is not in 
TLR4-/- mice.  
 
Materials and methods 
Animal care and protocol  
All protocols were approved by the ethical committee for animal 
use of the Université catholique de Louvain (Belgium) and the 
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housing conditions were as specified by the Belgian Law of April 6, 
2010 on the protection of laboratory animals (agreement n° LA 
1220548). 14-16-week-old male TLR4-/- (Hoshino et al., 1999)1 and 
C57BL/6J wild-type mice (WT) were purchased from Transgenose 
Institute (CNRS, Orléans, France) and the Laboratory of Experimental 
Surgery (UCL, Woluwé, Belgium), respectively. TLR4-/- genotype 
was confirmed by PCR. Animals were housed in cages per 4-5 in a 
controlled environment (22-23 °C, 14/10 h light/dark cycle). Mice 
were fed ad libitum with one of the two experimental diets during 18 
weeks: standard chow (chow) or high-fat diet (HFD). They were 
divided in four groups: WT mice fed with chow (n = 10) or HFD (n = 
9), TLR4-/- mice fed with chow (n = 9) or HFD (n = 8). Standard chow 
(10% calories from fat2, 4% calories from sucrose (Cani et al., 2004)) 
and HFD (45% calories from fat2, 17% calories from sucrose) were 
purchased from SAFE (A04, Augy, France) and Research Diets 
(D12451, New Brunswick, USA), respectively. Food intake was 
recorded weekly during the 18 weeks of the nutritional intervention. 
At the end of the protocol, 6-h-fasted mice were anesthetized with an 
intraperitoneal injection of a solution (4 ml.kg-1) containing ketamine 
(40 mg.ml-1) and xylazine (4 mg.kg-1) to preserve organ perfusion 
during dissection. The depth of anaesthesia was assessed by the 
absence of eyelid and pedal withdrawal reflexes.  
 
                                                          
1Generated by homologous recombination, the coding sequence of the transmembrane and cytoplasmic 
regions of TLR4 (amino acid residue 86-835) was replaced by a neomycin resistance gene. 
 
2Lipids composition HFD Chow 
% calories from saturated NEFA 17 2.1 
% calories from monounsaturated NEFA 21 1.6 
% calories from polyunsaturated NEFA 7 5.2 
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The right and left gastrocnemius muscles, the left lobe of the liver, the 
subcutaneous and visceral adipose tissues were rapidly removed and 
immediately frozen in liquid nitrogen. At the end of the procedure, 
mice were killed by cervical dislocation. Samples were stored at -80 
°C until processed.  
 
Non-esterified fatty acids measurement  
Blood samples were taken from portal vein and frozen at -20 C°. 
NEFA were measured by colorimetric assay according to the 
manufacturer’s guidelines (Diagnostic Systems, Holzheim, Germany).  
 
Protein extraction and Western blotting  
Liver (~50 mg), gastrocnemius (~50 mg) and subcutaneous adipose 
tissue (~100 mg) were ground using a mortar and a pestle (Bel-Art 
Products, Pequannock, NJ, USA). Liver and gastrocnemius were 
homogenised in ice-cold and pH 7.0 buffer [20 mM Tris, 270 mM 
sucrose, 5 mM EGTA, 1 mM EDTA, 1% Triton X-100, 1 mM sodium 
orthovanadate, 50 mM sodium β-glycerophosphate, 5 mM sodium 
pyrophosphate, 50 mM sodium fluoride, 1 mM 1,4-dithiothreitol 
(DTT), and 10% protease inhibitor cocktail 10X (Roche Applied 
Science, Vilvoorde, Belgium)]. Subcutaneous adipose tissue was 
homogenised in ice-cold pH 7.4 RIPA buffer [50 mM Tris-HCl, 150 
mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% deoxycholic acid, 2 mM 
sodium orthovanadate, 5 mM phenylmethylsulfonyl fluoride and a 
protease inhibitor cocktail (Roche Applied Science)]. Homogenates 
were centrifuged at 10,000 g for 10 min, at 4 °C. Supernatants were 
immediately stored at -80 °C. Protein concentration was determined 
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using the DC protein assay kit (Bio-Rad Laboratories, Nazareth, 
Belgium) with bovine serum albumin as a standard. Proteins lysates 
(40-60 µg) were combined with Laemmli buffer and separated by 
SDS-PAGE (10-12%) for 1 h at a constant intensity of 40 mA. 
Proteins were then transferred to PVDF membranes for 2-3 h at 
constant voltage of 80 V. Membranes were blocked for 1 h in Tris-
buffered saline with 0.1% Tween 20 (TBST) containing 5% non-fat 
dried milk. Then, membranes were incubated overnight at 4 °C in 
TBST containing 1% bovine serum albumin and one of the following 
primary antibodies (1:500 or 1:1000 dilution): BiP, phosphorylated-
eIF2α (p-eIF2α, Ser 51), phosphorylated-JNK (Thr183/Tyr185), 
phosphorylated ERK1/2 (Thr202/Tyr204), phosphorylated p-38 
(Thr180/Tyr182), IκB-α, phosphorylated IκB-α (Ser 32) and eEF2 
(eukaryotic elongation factor 2). All primary antibodies were obtained 
from Cell Signaling Technology (Leiden, The Netherlands). 
Membranes were washed three times with TBST then incubated 1 h at 
room temperature with a secondary antibody (1:10,000 or 1:5,000 
diluted in 5% non-fat dry milk) conjugated to horseradish peroxidase 
(Sigma, Bornem, Belgium). After three additional washes, 
chemiluminescent detection was carried out using an ECL Western 
blotting kit (Amersham ECL Plus, GE Healthcare, Diegem, Belgium). 
Pictures were taken with a charge-coupled device (CCD) camera 
(Gbox, Syngene, The Netherlands). Signal quantification was 
determined by GeneTool software (Syngene). All results were 
normalized to eEF2 protein then expressed relative to the control 
group (WT mice fed with chow). 
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RNA extraction and quantitative Real-time PCR  
Total RNA extraction from frozen gastrocnemius (~50 mg), liver 
(~30 mg) and subcutaneous adipose tissue (~70 mg) was done with 
Trizol® (Invitrogen, Vilvoorde, Belgium), according to the 
manufacturer’s instructions. The RNA quality and quantity were 
assessed by 1.5% agarose gel electrophoresis and Nanodrop® 
spectrophotometry. Reverse transcription was performed with iScript 
cDNA synthesis kit (Bio-Rad) from 1 µg total RNA. Real time PCR 
experiments were done on a MyIQ2 thermocycler (Bio-Rad) using the 
following conditions: 3 min at 95 °C, followed by 35 cycles of 30 s at 
95 °C, 30 s at 60 °C and 30 s at 72 °C. Samples were analyzed in 
duplicate in 10 µl reaction volume containing 4.8 µl IQSybrGreen 
SuperMix (Bio-Rad), 0.1 µl of each primer (100 nM final) and 5 µl 
cDNA. Primers sequences are reported in Table 5.1. Melting curves 
were systematically analyzed to ensure the specificity of the 
amplification process. Target genes were normalized using three 
reference genes according to geNorm analysis (Vandesompele et al., 
2002) and finally expressed relatively to the control group. The 
references genes were ribosomal protein L19 (RPL19), cyclophilin 
(CPHN) and hypoxanthine phosphoribosyltransferase 1 (HPRT1). 
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Oral glucose tolerance test  
Seventeen weeks after the beginning of the protocol, 6-h-fasted 
mice were force-fed with a glucose solution (1 g.kg-1 glucose, 40% 
glucose solution). Plasma glucose concentration was determined with 
a glucose meter (Roche Diagnostics) on 3.5 µl of blood collected from 
the tip of the tail vein, 30 min before and 0, 15, 30, 60, 90 and 120 
min following glucose gavage. Areas under the curve (AUC) were 
calculated according to the trapeze method. 
 
Statistical analysis 
Results are presented as means ± SEM. Two-way ANOVA was 
used to assess statistical differences amongst means. When 
appropriate, the Bonferroni test was used as a post-hoc analysis. The 
significative threshold was set for a P-value < 0.05. 
 
 
 
Table 5.1. Sequences of primers (5’-3’) 
Genes Forward Reverse 
XBP1s TGAGAACCAGGAGTTAAGAACACGC CCTGCACCTGCTGCGGAC 
XBP1u TGAGAACCAGGAGTTAAGAACACGC CACATAGTCTGAGTGCTGCGG 
 CHOP CCTGAGGAGAGAGTGTTCCAG CTCCTGCAGATCCTCATACCA 
RPL19 GAAGGTCAAAGGGAATGTGTTCA CCTTGTCTGCCTTCAGCTTGT 
CPHN CGTCTCCTTCGAGCTGTTTG CCACCCTGGCACATGAATC 
HPRT1 AGGCCAGACTTTGTTGGATTT CAGGACTCCTCGTATTTGCAG 
IL-6 ACTTCCATCCAGTTGCCTTCT GAATTGCCATTGCACAACTCT 
IL-1β GTCTGAAGCAGCTATGGCAAC 
 
TTTGAAGCTGGATGCTCTCAT 
 TNFα CCAGACCCTCACACTCAGATCA 
 
CACTTGGTGGTTTGCTACGAC 
 
XBP1s: X-box-binding protein 1 spliced, XBP1u: X-box-binding protein 1 unspliced, CHOP:  
C/EBP homologous, RPL19: Ribosomal protein L19, CPHN: Cyclophilin, HPRT1:  Hypoxanthine 
phosphoribosyltransferase 1, IL-6: interleukin-6, IL-1β: interleukin-1β TNFα: tumor necrosis 
factor-α. 
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Results  
TLR4 deficiency protects from obesity due to 18-weeks high-fat 
diet without reducing energy intake 
In basal conditions, body weight of TLR4-/- was higher than WT 
mice (~2.5 g, P < 0.001). After 18-weeks chow, body weight was 
increased by 5.4 ± 0.3 g in WT and 5.4 ± 0.4 g in TLR4-/- mice (Figure 
5.1A). This gain was 81% higher upon HFD in comparison with chow 
in WT (P < 0.001) but was not different in TLR4-/- mice (Figure 
5.1A). Compared to chow, visceral and subcutaneous adipose tissues 
were larger after HFD in WT (79% and 160% respectively, P < 0.001) 
but not in TLR4-/- mice (Figure 5.1C and 5.1D). When fed ad libitum 
with chow, TLR4-/- mice ingested more energy than WT (12.6 
kcal.week-1, P < 0.001) (Figure 5.1B). Upon HFD, the increase in 
weekly energy intake was larger in TLR4-/- mice (26%) than in WT 
(15%, P < 0.001) (Figure 5.1B). All together these results suggest that 
the energy expenditure of TLR4-/- is higher than WT mice. 
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Figure 5.1. TLR4 deficiency protects from obesity without reducing energy 
intake. (A) Body weight gain calculated as the body weight difference between the 
end (18 weeks) and the beginning of the diet. (B) Mean energy intake expressed in 
kcal.week-1 (C) Subcutaneous adipose tissue weight expressed in percentage of body 
weight. (D) Visceral adipose tissue weight expressed in percentage of body weight. 
Values are expressed as means ± SEM (n = 8-10), * P < 0.05, ** P < 0.01, *** P < 
0.001 
 
TLR4 deficiency protects from ER stress induced by a high-fat 
diet  
BiP expression increased in skeletal muscle (85%, P = 0.002), liver 
(150%, P = 0.031) and adipose tissue (188%, P = 0.039) of WT mice 
fed with a HFD, whereas TLR4-/- mice were completely resistant to 
HFD-induced BiP expression (Figure 5.2). The unspliced form of 
XBP1 mRNA (XBP1u) increased by 38% (P = 0.041) in skeletal 
muscle and by 48% (P = 0.01) in liver of WT mice upon HFD (Figure 
5.3). Unexpectedly, XBP1u transcripts decreased (-47%, P = 0.008) in 
adipose tissue of WT mice upon HFD (Figure 5.3). The spliced form 
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of XBP1 mRNA (XBP1s) increased by 34% (P = 0.026) in skeletal 
muscle of WT mice upon HFD (Figure 5.3). CHOP transcripts were 
up-regulated by HFD in skeletal muscle (27%, P = 0.041), liver (29%, 
P = 0.016) and adipose tissue (56%, P = 0.006) of WT mice (Figure 
3). HFD did not induce any change in ER stress markers in TLR4-/- 
mice (Figure 5.2 and Figure 5.3). 
 
Figure 5.2. ER stress protein markers are not induced in TLR4-/- mice after a 
high-fat diet. (A) Protein expression of BiP and phosphorylated eIF2α in skeletal 
muscle, liver and subcutaneous adipose tissue of wild-type (WT) and TLR4 
knockout (TLR4-/-) mice fed with a standard (chow) or a high-fat diet (HFD). 
Results are presented as means ± SEM (n = 8-10), * P < 0.05, ** P < 0.01, *** P < 
0.001. (B) Illustration of the data presented in panel A.  
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Figure 5.3. ER stress mRNA markers are not up-regulated in TLR4-/- mice 
after a high-fat diet. mRNA level of XBP1u (X-box-binding protein 1 unspliced), 
XBP1s (X-box-binding protein 1 spliced) and CHOP (C/EBP homologous) in 
skeletal muscle, liver and subcutaneous adipose tissue of wild-type (WT) and TLR4 
knockout (TLR4-/-) mice fed with a standard (chow) or a high-fat diet (HFD). 
Results are expressed as means ± SEM (n = 8-10), * P < 0.05, ** P < 0.01, *** P < 
0.001 
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TLR4 downstream signaling after a high-fat diet 
Since our results suggested that ER stress induced by a HFD is 
dependent upon TLR4, we decided to investigate the signaling 
downstream of TLR4 expecting to identify the mechanism by which 
TLR4 is able to activate ER stress. TLR4 leads to the activation of the 
NF-κB pathway, which regulates the transcription of cytokines such as 
IL-6, TNFα and IL-1β. Inflammation is known for inducing ER stress 
(Zhang and Kaufman, 2008). None of the cytokines that we measured 
was increased after HFD (Figure 5.4A). Furthermore, the HFD did not 
increase the phosphorylation state of IκB-α and did not decrease IκB-α 
protein level (Figure 5.4B). Nevertheless, in the adipose tissue, IκB-α 
was 70% higher in TLR4-/- than in WT mice as evidenced by the 
significant between-strain effect of the ANOVA design (P = 0.027). In 
the same tissue, the level of phospho-IκB-α was undetectable in all 
conditions. 
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Figure 5.4. NFκB pathway is not implicated in HFD-induced ER stress. (A) 
mRNA level of IL-6 (interleukin-6), IL-1β (interleukin-1β), TNFα (tumor necrosis 
factor-α) are measured in skeletal muscle, liver and subcutaneous adipose tissue of 
wild-type (WT) and TLR4 knockout (TLR4-/-) mice fed with a standard (chow) or a 
high-fat diet (HFD) (B) Phosphorylation state and expression of IκB-α in skeletal 
muscle, liver and subcutaneous adipose tissue of wild-type (WT) and TLR4 
knockout (TLR4-/-) mice fed with a standard (chow) or a high-fat diet (HFD). 
Results are presented as means ± SEM (n = 8-10), * P < 0.05, ** P < 0.01, *** P < 
0.001 
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The phosphorylation state of the mitogen-activated protein kinases 
(MAPK) is under the control of the TLR4 pathway (Akira and Sato, 
2003). HFD did not change the phosphorylation state of p-38 in all 
investigated organs (Figure 5.5). In skeletal muscle, the 
phosphorylation state of ERK1/2 was 44% lower in TLR4-/- than in 
WT mice (between-strain effect: P = 0.033). The phosphorylation 
state of ERK1/2 decreased in skeletal muscle (-51%, P = 0.016) and 
liver (-35%, P = 0.019) of WT mice upon HFD whereas it was not 
affected in TLR4-/- mice (Figure 5.5). After HFD, the phosphorylation 
state of ERK1/2 was 95% higher in adipose tissue of WT than TLR4-/- 
mice (P = 0.025) (Figure 5.5). The phosphorylation state of JNK did 
not change in skeletal muscle and liver, whereas it was dramatically 
increased by 169% in adipose tissue of WT mice upon HFD (P < 
0.001) (Figure 5.5). The phosphorylation state of JNK remained 
unaffected in TLR4-/- mice (Figure 5.5). These results emphasize the 
fact that HFD regulates MAPK activity mainly at the level of the 
adipose tissue. 
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Figure 5.5. Changes in MAPK phosphorylation after a high-fat diet in wild-
type and TLR4-/- mice. (A) Phosphorylation state of p38, JNK and ERK1/2 in 
skeletal muscle, liver and subcutaneous adipose tissue of wild-type (WT) and TLR4 
knockout (TLR4-/-) mice fed with a standard (chow) or a high-fat diet (HFD). 
Results are presented as means ± SEM (n = 8-10), * P < 0.05, ** P < 0.01, *** P < 
0.001. (B) Illustration of the data presented in panel A. 
 
Oral glucose tolerance test and plasma NEFA  
To assess glucose tolerance, we performed an oral glucose 
tolerance test (OGTT). After 18-weeks chow, AUC was slightly but 
not significantly larger in TLR4-/- than in WT mice (Figure 5.6A). WT 
mice fed with HFD developed glucose intolerance as demonstrated by 
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a higher AUC (45%, P = 0.01), whereas no significant change was 
observed in TLR4-/- mice (Figure 5.6A). The circulating NEFA 
measured in a fasted state were not significantly lower in TLR4-/- mice 
and were not affected by the HFD (Figure 5.6B). 
 
Figure 5.6. OGTT and circulating NEFA after a high-fat diet in wild-type and 
TLR4-/- mice. (A) Plasma glucose concentration following an oral glucose load. 
Wild-type mice upon chow (○), wild-type mice upon a high-fatd diet (●), TLR4 
knockout mice upon chow (), TLR4 knockout mice upon a high-fat diet (). The 
inset represents the area under the curve (AUC) expressed in arbitrary units (A.U.). 
(B) Fasting NEFA concentrations expressed in mmol.L-1. 
 
Discussion 
TLR4 deficiency protects against ER stress induced by a HFD 
The main finding of the present study is that TLR4 deficiency 
protects against ER stress induced by a HFD. BiP is a chaperone that 
plays a key role in activating cell response to ER stress and its 
expression is highly regulated by the UPR (Lee, 2001). In WT mice, 
BiP was increased during HFD in skeletal muscle, liver and adipose 
tissues whereas TLR4-/- mice did not show any change. The three 
branches of the UPR are able to regulate BiP, which is therefore 
considered as the endpoint marker of the UPR whatever the activated 
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signaling cascade. Consequently, our results confirm the presence of 
an ER stress in skeletal muscle, liver and adipose tissues of WT mice 
after a HFD (Deldicque et al., 2010, Ozcan et al., 2004). BiP was 
unaffected in TLR4-/- mice fed with a HFD suggesting that this 
receptor contributes to the development of ER stress induced by lipid 
excess. 
CHOP is another well-recognized ER stress marker, which is 
coordinately regulated with BiP (Wang et al., 1996). CHOP is a 
family member of the ER stress-inducible genes, the transcription of 
which is regulated both by ATF6 and ATF4, the latter being a 
downstream effector of the PERK/eIF2α pathway (Zhang and 
Kaufman, 2008). In WT, CHOP mRNA was increased after a HFD in 
the three organs analysed in the present study. No changes were 
observed in TLR4-/- mice supporting the results obtained on BiP. 
XBP1u is also a member of the ER stress-inducible gene family, 
which is regulated by ATF6 (Yoshida et al., 2001, Lee et al., 2002). In 
skeletal muscle and liver, XBP1u mRNA was increased in WT after 
HFD whereas this change was completely abolished in TLR4-/- mice. 
These results suggest that the ATF6 pathway was not activated in 
skeletal muscle and liver of TLR4-/- mice while it was in WT mice. 
XBP1u seems regulated differently in adipose tissue. Upon chow, 
XPB1u mRNA was lower in TLR4-/- than in WT mice. It decreased in 
WT after HFD and remained unchanged in TLR4-/- mice. This clearly 
indicates that the regulation of the UPR by a HFD is tissue-specific.  
XBP1s was undetectable in adipose tissue. In all conditions, the 
values of cycle threshold (Ct) were higher than 35 and therefore, were 
not accurate enough for interpretation (Nolan et al., 2006). This was 
TLR4-/- mice are protected against ER stress induced by a HFD 85 
 
 
not the case in skeletal muscle wherein XBP1s was increased in WT 
upon HFD, but not in TLR4-/- mice. This indicates that the IRE1α 
pathway was likely activated in WT and that this activation was 
lacking in TLR4-/- mice. No changes were observed in XPBls mRNA 
in liver of WT and TLR4-/- mice. This provides an additional 
argument for a tissue-specific regulation of the UPR by a HFD (Ye et 
al., 2010). 
We measured the phosphorylation state of eIF2α as a marker of the 
PERK pathway activation. In our experimental conditions, phospho-
eIF2α was affected neither by the mice strain, nor by the diet.  
In WT mice fed with HFD, several ER stress markers were 
increased while others did not change. A distinction must be made in 
the interpretation of ER stress marker changes. On one hand, the 
phosphorylation of eIF2α and the splicing of XBP1 are direct markers 
of UPR activation (Malhotra and Kaufman, 2007). On the other hand, 
BiP, CHOP and unspliced XBP1 are called ER stress-inducible genes, 
meaning that they are the consequence of UPR. They represent a long 
term adaptation to a stress condition and may be continuously 
overexpressed to cope with ER stress. On the contrary, XBP1 splicing 
and eIF2α phosphorylation seem to be transiently activated. For 
example, the activation of the PERK pathway is dependent on the 
acute nutritional status (Oyadomari et al., 2008). Oyadomari et al. 
(2008) shown that the phosphorylation of eIF2α is barely detectable in 
the liver of fasted animals and increased 4 hours after feeding standard 
diet; this effect was higher in animals fed with HFD. Since the 
animals used in the present experiment were sacrificed after a fasted 
period of 6 hours, it is possible that we missed transient changes in the 
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phosphorylation state of eIF2α. Furthermore, caution must be taken 
when interpreting result from eIF2α phosphorylation as a consequence 
of ER stress. Beside the control of PERK, eIF2α can also be 
phosphorylated by three other kinases, namely PKR (protein kinase 
R), GCN2 (general control nonrepressed 2), HRI (Heme-regulated 
inhibitor kinase) and dephosphorylated by GADD34 (Protein 
phosphatase 1 regulatory subunit 15A) (Novoa et al., 2001, Williams, 
1999, Berlanga et al., 1999).  
 
NFκB pathway is not implicated in HFD-induced ER stress 
The results of the present study support the presence of 
interdependency between TLR4 and ER stress. We tried to further 
understand how the absence of TLR4 could down-regulate ER stress. 
Our first hypothesis was based on a reduced activation of the NF-κB 
pathway in TLR4-/- mice after a HFD, which would reduce the 
inflammatory state and consequently ER stress. This hypothesis was 
not corroborated as the NF-κB pathway was not activated after a HFD 
in WT and TLR4-/- mice in our conditions. The mRNA level of 
cytokines regulated by NF-κB, namely TNFα, IL-1β and IL-6 (Zhang 
and Kaufman, 2008), was not changed and IκB-α, an inhibitory 
protein of NF-κB, was not decreased after HFD and it phosphorylation 
state was not affected. 
It has been reported that circulating LPS, the main TLR4 ligand, 
was increased after a HFD likely because of a more leaky gut (Cani et 
al., 2007, Cani et al., 2008, Kim et al., 2012). Studies showed that LPS 
induced ER stress in lung (Endo et al., 2006), human B cells 
(Kuribayashi et al., 2008) and liver (Kozlov et al., 2009). Plasma LPS 
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was not measured in the present study. Therefore, we may not rule out 
that circulating LPS induced ER stress in WT and not in TLR4-/- mice. 
Nevertheless, this hypothesis seems unlikely because of the lack of 
NF-κB activation in TLR4-/- and WT mice. 
In vitro and in vivo studies suggest that TLR4 recognizes NEFA in 
addition to LPS (Shi et al., 2006, Lee et al., 2001). Like others 
(Garbow et al., 2011, Gao et al., 2010), we did not observe any 
difference in plasma NEFA concentration after a HFD arguing against 
a NEFA-dependent activation of TLR4 during a HFD. Nevertheless, 
the blood samples were taken in a fasted state and therefore, we may 
not exclude a transitory increase of circulating NEFA during the 
postprandial phase. 
 
TLR4 deficiency protect against body weight gain and adipose 
tissue extension induced by a HFD 
In addition to the protection from ER stress, others and we 
observed that the deletion of the gene coding for TLR4 provides also a 
protection against obesity (Radin et al., 2008, Tsukumo et al., 2007, 
Saberi et al., 2009), probably because of a more favorable energy 
balance. In parallel to body weight gain, we and others showed that 
TLR4 deficiency protects from visceral and subcutaneous adipose 
tissue expansion induced by a HFD (Tsukumo et al., 2007, Davis et 
al., 2008, Radin et al., 2008). Upon chow, the energy intake was 
higher in TLR4-/- than in WT mice whereas the body weight gains 
were similar. Upon HFD, both genotypes increased energy intake, 
which was the largest in TLR4-/- mice as previously reported 
(Tsukumo et al., 2007, Davis et al., 2008). Since the body weight gain 
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was lower in TLR4-/- than in WT mice, it is likely that fat absorption 
and/or energy expenditure were altered. To the best of our knowledge, 
no results have been reported regarding an impaired fat absorption in 
TLR4 deficient mice submitted to a HFD. Indirect calorimetry 
measurements demonstrated that energy expenditure and fatty acids 
utilization were increased upon a HFD in mice with a loss of function 
mutation of the gene coding for TLR4 (C3H/HeJ) (Tsukumo et al., 
2007). Frisard et al. (2010) showed that the skeletal muscle of 
C3H/HeJ mice exhibits an increased fatty acid oxidation, citrate 
synthase activity and beta-hydroxyacyl CoA dehydrogenase activity 
(Frisard et al., 2010). Therefore, the metabolic consequences related to 
fat storage could explain the presence of an ER stress in WT after a 
HFD without a direct implication of the NF-κB pathway. In TLR4-/- 
mice, the metabolic changes towards greater energy expenditure and 
reduced body fat content would be protective. 
 
TLR4 deficiency protects from glucose intolerance induced by a 
HFD 
Recent findings showed that high glucose level induces ER stress, 
probably via the glucosamine pathway (Srinivasan et al., 2009, Buse, 
2006). Indeed, an elevated glucose level causes ER stress in primary 
cardiomyocytes (Younce et al., 2010), endothelial cells (Sheikh-Ali et 
al., 2010), liver (Beriault et al., 2011) and adipocytes (Alhusaini et al., 
2010). Glucose level was slightly increased in the fasted state after 
HFD, but the concentrations were not different between WT and 
TLR4-/- mice. In the present study, glucose tolerance was assessed by 
an OGTT test. In the chow condition, there was no statistical 
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difference between WT and TLR4-/-. After having received a HFD, 
WT mice became glucose intolerant whereas no difference was 
observed in TLR4-/- mice. This confirms other studies showing that 
TLR4 deficient mice are protected from insulin resistance induced by 
lipid infusion or a HFD (Shi et al., 2006, Radin et al., 2008, Tsukumo 
et al., 2007, Kim et al., 2007, Davis et al., 2008, Poggi et al., 2007). 
High sucrose diet has also been linked to insulin resistance (Dutta et 
al., 2001, Pagliassotti et al., 1994). In the HFD used in the present 
experiment, the sucrose content was higher than in chow (17 kcal% vs 
4 kcal%), but far from the 60-70 kcal% usually used in the high 
sucrose diets (Omar et al., 2012, Dutta et al., 2001). Therefore, it is 
likely that ER stress and insulin resistance observed in WT and not in 
TLR4-/- mice after HFD is mostly due the fat content of the diet even 
if we may not rule out a partial indirect contribution of sucrose. 
In human, TLR4 is more expressed in skeletal muscle of obese type 
2 diabetic patients than lean healthy subjects (Reyna et al., 2008). 
These results are associated with a positive correlation between TLR4 
protein content and insulin resistance, suggesting that TLR4 might be 
an actor of the process linking inflammation and insulin resistance in 
mice as well as in human. A broad spectrum of evidence suggests that 
TLR4 controls its own expression. For example, incubation of human 
primary myotubes with palmitate or lipid A, the LPS-binding domain 
of TLR4, increases its expression (Reyna et al., 2008). On the 
contrary, TLR4 mRNA is reduced in skeletal muscle of frail obese 
elderly patients after 12 weeks exercise training (Lambert et al., 
2008). Endoplasmic reticulum dysfunction due to lipid excess is also 
known to disrupt insulin signal in mice (Ozcan et al., 2004). In human, 
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ER stress was observed in liver and adipose tissue of obese patients 
(Puri et al., 2008, Boden et al., 2008) and it was reduced after weight 
loss (Gregor et al., 2009). All together these results and those reported 
in the present paper suggest that a down-regulation of TLR4 or a 
reduced stimulation of this receptor by nutritional, pharmacological 
and/or exercise interventions could reveal a novel strategy for 
reducing low grade inflammation and ER stress-induced insulin 
resistance.  
 
TLR4 deficiency protects from HFD-induced JNK activation in 
adipose tissue 
TLR4 appears to mediate the signal linking obesity to insulin 
resistance. However, the underlying mechanisms are unclear and seem 
to be organ-dependent (Kim and Sears, 2010). In the present study, we 
found that TLR4 was essential for inducing ER stress in the insulin-
sensitive tissues during a HFD. ER stress is now recognized as a 
central mechanism responsible for insulin resistance (Zhang and 
Kaufman, 2008). Indeed, activated IRE1α recruits TRAF2 (tumour-
necrosis factor-α-receptor-associated factor 2) and triggers JNK 
phosphorylation (Urano et al., 2000). The phosphorylation of JNK 
mediates in turn the phosphorylation of IRS1 (insulin-receptor 
substrate 1) on serine residues which is known to inhibit 
phosphorylation of IRS1 on tyrosine residues causing insulin 
resistance (Hirosumi et al., 2002). In our study, the phosphorylation 
state of JNK was only affected in adipose tissue of WT mice after 
HFD whereas this effect was completely abolished in TLR4-/-. 
Consequently, it is likely that TLR4 contributes to JNK 
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phosphorylation through ER stress in adipose tissue. This result 
supports the idea that the mechanism by which TLR4 mediates insulin 
resistance is organ-dependent. XBP1s mRNA was undetectable in 
adipose tissue and therefore we have no direct measurement of the 
activation of IRE1α in this tissue.  
Independently of the UPR, ER stress induces an increase of lipid 
droplets (Zhang and Zhang, 2012). The intracellular lipid 
accumulation is known to disrupt insulin pathway through the 
generation of lipid-derived toxic metabolites such ceramides and DAG 
(Summers, 2006, Idris et al., 2001). Intracellular lipids were not 
measured in this study. Consequently, we may not rule out an 
implication of intracellular lipids in the link between TLR4 
dependent-ER stress and insulin resistance. 
 
Conclusion 
TLR4 deficiency protects from obesity and glucose intolerance 
induced by a HFD as well as from ER stress in the main organs for 
glucose and lipid metabolism (skeletal muscle, liver and adipose 
tissue). Contrary to our hypothesis this phenomenon is not directly 
regulated by the NF-κB pathway but seems rather to be the indirect 
consequence of metabolic changes in TLR4-/- mice which lead to less 
fat accumulation. 
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Abstract 
The purpose of this study was to examine the link between oxidative 
stress and endoplasmic reticulum (ER) stress in myogenic cells. 
C2C12 myotubes were incubated with hydrogen peroxide (H2O2, 200 
µM) and harvested 4 h or 17 h after the induction of this oxidative 
stress. A massive upregulation of binding immunoglobulin protein 
(BiP) was found, indicating the presence of ER stress. Nevertheless, 
the three branches of the unfolded protein response (UPR) were not 
activated to the same extent. The double-stranded RNA-dependent 
protein kinase (PKR)-like ER kinase (PERK) branch was the most 
activated as shown by the increase of phospho-eukaryotic translation-
initiation factor 2α (eIF2α, Ser51) and the mRNA levels of activating 
transcription factor 4 (ATF4), C/EBP homologous (CHOP) and 
tribbles homolog 3 (TRB3). The slight increase in the spliced form of 
X-box binding protein 1 (XBP1s) together with the decrease of the 
unspliced form (XBP1u) indicated a higher endoribonuclease activity 
of inositol-requiring 1α (IRE1α). The transcriptional activity of 
activating transcription factor 6 (ATF6) remained unchanged after 
incubation with H2O2. The mechanisms by which the three branches 
of UPR can be specifically regulated by oxidative stress are currently 
unresolved and need further investigations. 
 
Keywords 
Unfolded protein response (UPR), oxidative stress, binding 
immunoglobulin protein (BiP), activating transcription factor 6 
(ATF6), X-box binding protein 1 spliced (XBP1s), eukaryotic 
translation-initiation factor 2α (eIF2α) 
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Introduction 
Oxidative stress is due to an imbalance between free radical 
production and antioxidant capacity of the cell. Mitochondria produce 
reactive oxygen species (ROS) like superoxide, which is converted 
into hydrogen peroxide (H2O2) by the reaction catalysed by 
superoxide dismutase (SOD). ROS are recognized as signaling 
molecules regulating physiological and pathological events (Veal et 
al., 2007). Nowadays, endoplasmic reticulum (ER) appears to be a key 
player in the integration and sensing oxidative signals (Malhotra and 
Kaufman, 2007b). 
ER is a vast membranous network surrounding the nucleus. This 
organelle provides an oxidizing and high calcium environment where 
most secreted and membrane proteins are folded (Zhang and 
Kaufman, 2008). Increasing protein load relative to the folding 
capacity of the ER leads to accumulation of unfolded proteins, a 
condition known as ER stress. To cope with this stress, eukaryotic 
cells have developed an adaptive response called the unfolded protein 
response (UPR). Unfolded proteins are sensed by three ER 
transmembrane proteins: inositol-requiring 1α (IRE1α), double-
stranded RNA-dependent protein kinase (PKR)-like ER kinase 
(PERK) and activating transcription factor 6 (ATF6). Under 
unstressed conditions, each of these ER stress sensors is maintained in 
an inactive state through binding with the protein chaperone binding 
immunoglobulin protein (BiP). Upon ER stress, BiP is released, 
leading to activation of the three sensors and downstream signaling. 
UPR pathways rapidly inhibit protein synthesis through the 
phosphorylation of eukaryotic translation-initiation factor 2α (eIF2α). 
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This step is followed by a transcriptional upregulation of specific 
genes coding for proteins implicated in folding, transport and ER-
associated degradation (ERAD). If these adaptive responses fail to 
restore ER homeostasis, an apoptotic response mediated by C/EBP 
homologous (CHOP) is induced (Zhang and Kaufman, 2008). 
High concentrations in lipids activate ER stress in various organs 
like pancreas, liver and adipose tissue (Ozcan et al., 2004, Laybutt et 
al., 2007), but also in C2C12 myogenic cells and skeletal muscle of 
mice (Pierre et al., 2013, Deldicque et al., 2010). In human muscle, 
ER stress has been observed in sporadic inclusion body myositis, 
polymyositis, and type 2 diabetes (Vattemi et al., 2004, Koh et al., 
2013). The mechanisms triggering ER stress in muscle cells are still 
incompletely resolved. Recent studies have shown physical and 
biochemical interactions between mitochondria and ER (Csordas and 
Hajnoczky, 2009). On the one hand, ER and mitochondria are 
physically associated at the level of a sub-compartment called 
mitochondria-associated ER membrane (MAM). On the other hand, 
calcium and ROS are key molecules involved in the communication 
between mitochondria and ER. For example, mitochondrial ROS can 
target ER-based calcium channels leading to calcium release from the 
ER to the cytosol. The perturbation of ER calcium homeostasis 
disrupts protein folding and induces ER stress (Csordas and 
Hajnoczky, 2009). It has been shown that oxidative stress induces ER 
stress in murine fibrosarcoma cells (L929), murine mesencephalic 
cells (MN9D), human retinal pigment epithelium (RPE) cells, Chinese 
hamster ovary (CHO) cells, HeLa cells and heart cells (H9c2) (Xue et 
al., 2005, Holtz et al., 2006, He et al., 2008, Borradaile et al., 2006, 
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Pallepati and Averill-Bates, 2011). However, the pattern of UPR 
activation seems dependent on cell types. In HeLa cells, H2O2 
activates the three UPR pathways (Pallepati and Averill-Bates, 2011) 
whereas in L929 cells, H2O2 activates the PERK pathway but not the 
IRE1 pathway (Xue et al., 2005). 
Because muscle cells are great ROS providers (Barbieri and Sestili, 
2012), oxidative stress is a potential regulator of ER stress in these 
cells. Therefore, the purpose of this study was to investigate whether 
oxidative stress could induce ER stress in the C2C12 myogenic cell 
line and to identify which signaling pathways of UPR are specifically 
activated. 
 
Materials and Methods 
Cell culture  
C2C12 mouse myoblasts (ATCC, USA) were cultured at 37 °C in a 
humidified incubator containing 5% CO2. Cells were seeded in 8.8 
cm2 culture dishes (Nunc, Belgium) and grown in a high glucose (4.5 
g/L) Dulbeccos’s Modified Eagle Medium (DMEM, Life 
Technologies, USA) supplemented with 10% (v/v) foetal bovine 
serum, 100 U/ml penicillin and 100 µg/ml streptomycin (Life 
Technologies). When cells reached confluence (48 h), medium was 
replaced by a differentiation medium containing DMEM, 2% (v/v) 
horse serum (Lonza, Belgium), 100 U/ml penicillin and 100 µg/ml 
streptomycin. After 96 h of differentiation, 200 µM hydrogen 
peroxide (Sigma-Aldrich, Belgium) or 1 µM thapsigargin (Tocris 
Bioscience, UK) or appropriate solvent in control condition (i.e., 
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water for hydrogen peroxide and DMSO for thapsigargin) was added 
to the dishes. Cells were harvested after 4 or 17 h. 
 
Western blotting 
Cells were lysed in ice-cold and pH 7.0 lysis buffer containing 20 
mM Tris, 270 mM sucrose, 5 mM EGTA, 1 mM EDTA, 1 mM 
sodium orthovanadate, 50 mM β-glycerophosphate, 5 mM sodium 
pyrophosphate, 50 mM sodium fluoride, 1 mM DTT (1,4-
dithiothreitol), 0.1% (v/v) Triton X-100 and 10% protease inhibitor 
cocktail (Roche Applied Science, Belgium). The homogenates were 
then centrifuged at 10,000 g for 10 min, at 4 °C. Protein concentration 
was determined using the Detergent Compatible (DC) protein assay 
kit (Bio-Rad Laboratories, Belgium). Cell lysates were separated by 
SDS/PAGE and transferred to polyvinylidene fluoride (PVDF) 
membrane (GE Healthcare, Belgium). Membranes were blocked for 1 
h in a Blotto solution containing Tris-buffered saline with 0.1% (v/v) 
Tween 20 (TBST) with 5% (w/v) non-fat dried milk. Then, 
membranes were incubated overnight at 4 °C with the following 
primary antibodies: eukaryotic elongation factor 2 (eEF2), BiP, 
IRE1α, protein disulfide isomerase (PDI), phosphorylated-eIF2α 
(Ser51), phosphorylated-JNK (Thr183/Tyr185). All primary 
antibodies were from Cell Signaling Technology (The Netherlands). 
Then membranes were incubated for 1 h at room temperature with a 
secondary antibody. Proteins were finally detected using Enhanced 
Chemiluminescence (ECL) Western blotting Detection System Plus 
(GE Healthcare). The films were then scanned on an ImageScanner 
using the Labscan software and quantified with the Image Master 1D 
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Image Analysis Software (GE Healthcare). All results were 
normalized to eEF2 protein and finally expressed relatively to the 
control condition. 
 
RNA extraction and quantitative Real-Time PCR  
Total RNA extraction from cells was done with Trizol (Life 
Technologies), according to the manufacturer’s instructions. The RNA 
quality was assessed by 1.5% (w/v) agarose gel electrophoresis, while 
the quantity and purity were measured by NanoDrop® 
spectrophotometer (Isogen Life Science, Belgium). Reverse 
transcription was performed with iScript cDNA synthesis kit (Bio-
Rad) from 1 µg total RNA. Real time PCR experiments were done on 
a MyIQ2 thermocycler (Bio-Rad). Samples were analyzed in duplicate 
in 10 µl reaction volume containing 4.8 µl IQSybrGreen SuperMix 
(Bio-Rad), 0.1 µl of each primer (100 nM final concentration) and 5 µl 
of cDNA. Primers sequences are reported in Table 6.1. Melting curves 
were systematically analyzed to ensure the specificity of the 
amplification process. Relative quantities were calculated with the 
standard curve method. Target genes were normalized using three 
reference genes according to the geNorm analysis (Vandesompele et 
al., 2002) and finally expressed relatively to the control group. The 
reference genes were cyclophilin (CPHN), glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and beta-2-microglobulin 
(B2M3). 
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Table 6.1. Sequences of primers (5’-3’) 
Primers Forward Reverse 
BiP CTATTCCTGCGTCGGTGTGT GCAAGAACTTGATGTCCTGCT 
CHOP CCTGAGGAGAGAGTGTTCCAG CTCCTGCAGATCCTCATACCA 
XBP1u TGAGAACCAGGAGTTAAGAACACGC CACATAGTCTGAGTGCTGCGG 
XBP1s TGAGAACCAGGAGTTAAGAACACGC CCTGCACCTGCTGCGGAC 
ATF4 GAGCTTCCTGAACAGCGAAGTG TGGCCACCTCCAGATAGTCATC 
TRB3 TGTGAGAGGACGAAGCTGGTG TCGTGGAATGGGTATCTGCC 
CPHN CGTCTCCTTCGAGCTGTTTG CCACCCTGGCACATGAATC 
GAPDH TGGAAAGCTGTGGCGTGAT TGCTTCACCACCTTCTTGAT 
B2M3 AAGCCGAACATACTGAACTGC CGTCTACTGGGATCGAGACAT 
 
BiP: binding immunoglobulin protein, CHOP: C/EBP homologous, XBP1u: X-box-binding protein 1 
unspliced, XBP1s: X-box-binding protein 1 spliced, ATF4: activating transcription factor 4, TRB3: 
Tribbles homolog 3, CPHN: Cyclophilin, GAPDH: Glyceraldehyde-3-phosphate dehydrogenase, 
B2M3: Beta-2-microglobulin. 
 
Plasmids and cell transfection  
ATF6 transcriptional activity has been detected with Luciferase 
reporter genes. p5xATF6-GL3 plasmid (Addgene plasmid 11976) 
contains five repeats of the ATF6 binding site cloned into a minimal 
promoter preceding the firefly luciferase gene (Wang et al., 2000). 
Renilla plasmid was used to normalize transfection efficiency. 
Plasmids were amplified in XL1-Blue (Stratagene, USA) and purified 
with the NucleoBond Xtra Maxi Plus Kit (Macherey-Nagel, Belgium). 
C2C12 myoblasts were co-transfected (Amaxa Nucleofector™ 
Technology, Lonza) at 50-60% confluence according to the 
manufacturer’s instructions. C2C12 myoblasts (1.106) were suspended 
in 100 µl of mouse neuron Nucleofector solution (Lonza) with 2.5 µg 
of p5xATF6-GL3 and 2.5 µg of Renilla plasmid. Then, cells were 
nucleofected and cultivated as described above. After appropriate 
treatment, cells were lysed with Passive Lysis Buffer (Promega, The 
Netherlands) and assayed for firefly and Renilla luciferase activities 
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using the Dual Luciferase Reporter Assay System (Promega). Firefly 
luciferase activity was reported to Renilla luciferase activity. 
 
Statistical analysis  
All results were expressed relatively to the control group and are 
presented as means ± SEM. Three independent cultures were used. In 
each culture, the results were generated in duplicate or triplicate. 
Student test or one-way ANOVA was used to assess statistical 
differences amongst means. When appropriate, the Dunnett’s method 
was used as a post-hoc analysis. The significance threshold was set for 
a P-value < 0.05. Statistical significance is indicated in figures with * 
(P < 0.05) and ** (P < 0.01). 
 
Results 
H2O2 increases the transcription of UPR-inducible genes  
Transcripts coding for several proteins involved in UPR were 
regulated upon H2O2 in C2C12 myotubes. Four hours after H2O2 
exposure, the spliced form of X-box binding protein 1 (XBP1s) 
increased by 64% (P < 0.01) whereas the unspliced form (XBP1u) 
decreased by 23% (P = 0.021) (Figure 6.1A). The two forms of XBP1 
were not modified 17 h after H2O2 exposure (Figure 6.1B). Short- (4 
h) and long-term (17 h) response to H2O2 exposure increased the 
transcript coding for the chaperone BiP (65%, P < 0.01 and 98%, P = 
0.014; respectively) (Figure 6.1). Four hours after H2O2 treatment, 
activating transcription factor 4 (ATF4), CHOP and tribbles homolog 
3 (TRB3) mRNA increased by 82% (P < 0.01), 331% (P < 0.01) and 
165% (P < 0.01) respectively (Figure 6.1A). A longer period (17 h) 
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induced a higher increase of ATF4 (141% P = 0.011) CHOP (17-fold, 
P < 0.01) and TRB3 (34-fold, P < 0.01) mRNA (Figure 6.1B). 
 
 
Figure 6.1. mRNA levels of XBP1u, XBP1s, BiP, ATF4, CHOP and TRB3 
measured in C2C12 myotubes after 4 h (A) or 17 h (B) of H2O2 exposure. Results 
are expressed as means ± SEM (n = 3); ns, not-significant (P ≥ 0.05); * P < 0.05; ** 
P < 0.01. 
 
H2O2 increases the expression of ER stress protein markers  
The protein chaperone BiP was increased 4 h (683%, P < 0.01) and 
17 h after H2O2 exposure (674% P < 0.01) (Figure 6.2). These results 
confirm those obtained by mRNA analysis (Figure 6.1). The 
phosphorylation state of eIF2α increased 5-fold (P = 0.02) 4 h after 
H2O2 exposure and was maintained until 17 h (336%, P < 0.01). The 
protein expression of IRE1α did not change 4 h after H2O2 exposure 
whereas it increased by almost 8-fold (P < 0.01) after 17 h. Finally, 
PDI protein and the phosphorylation state of JNK were not modified 
by H2O2 (Figure 6.2). 
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Figure 6.2. Protein expression of BiP, IRE1α, PDI, phosphorylation state of eIF2α 
and JNK measured in C2C12 myotubes after 4 h or 17 h of H2O2 exposure. Results 
are expressed as means ± SEM (n = 3); ns, not-significant (P ≥ 0.05); * P < 0.05; ** 
P < 0.01. 
 
H2O2 does not activate the ATF6 pathway  
The activation of the ATF6 branch of UPR was assessed by 
measuring the transcriptional activity of this protein. Four hours and 
17 h after H2O2 exposure, the transcriptional activity of ATF6 did not 
change (Figure 6.3). In contrast, it was increased by 2-fold (P < 0.01) 
after 4 h thapsigargin treatment and by 24-fold (P < 0.01) after 17 h 
(Figure 6.3A and 6.3B). 
108   Chapter 6 
 
 
Figure 6.3. Relative ATF6 activity measured by the p5xATF6-GL3 plasmid 
luciferase activity normalized to the Renilla luciferase activity in C2C12 myotubes 
after 4 h (A) or 17 h (B) of H2O2 exposure. Results are expressed as means ± SEM 
(n = 3); ns, not-significant (P ≥ 0.05); * P < 0.05; ** P < 0.01. 
 
Discussion 
Muscle cells are highly exposed to oxidant molecules. In this 
context, detection and response to oxidative stress is critical for cell 
survival. In this study, we show that ER of C2C12 myotubes senses 
and responds to oxidative stress. Indeed, H2O2 treatment activates 
UPR and increases the level of BiP, a well-recognized marker of ER 
stress (Lee, 2005). Due to its diffusion capacity across cell 
membranes, H2O2 has been widely used as a model of oxidative stress 
(Veal et al., 2007). Nevertheless, the highly reactive nature of ROS 
implicates a rapid disappearance of the stress inducer. Gülden et al. 
(2010) showed that H2O2 (200 µM) was almost completely eliminated 
from the culture medium of C6 glioma cells after 1 h (Gulden et al., 
2010). In this study, we decided to investigate a short- (4 h) and a 
long-term (17 h) response after an oxidative stress induced by 200 µM 
H2O2. Preliminary experiments (data not shown) and results from the 
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literature (Nishida et al., 2007) led us to choose this concentration 
because it was the best compromise between cell survival and 
activation of the UPR. 
IRE1 pathway is the only common branch of UPR between lower 
eukaryotes and metazoans (Walter and Ron, 2011). When unfolded 
proteins accumulate into ER, BiP dissociates from IRE1α leading to 
its homodimerization and trans-autophosphorylation that in turn, 
activates its kinase and endoribonuclease (RNAse) domains. IRE1 
RNAse cleaves an intron from XBP1 mRNA, which induces a 
translational frame shift. The isoform resulting from XBP1s mRNA 
translation is a potent transcription factor that binds to the consensus 
mammalian ER stress response element (ERSE) (Zhang and Kaufman, 
2008). Consequently, the spliced form of XBP1 mRNA (XBP1s) is a 
proximal and specific marker of the IRE1 pathway. Our results 
showed an increase of XBP1s after H2O2 exposure as well as a 
decrease of the unspliced form giving arguments for an activation of 
the IRE1 branch of UPR.  
Our results confirm a recent study showing an activation of IRE1 
by H2O2 in HeLa cells (Pallepati and Averill-Bates, 2011) but not 
those reported by Xue et al. (2005) who did not observe any change of 
XBP1s upon H2O2 treatment (1 mM for 1-8 h) in L929 fibroblasts 
(Holtz et al., 2006). In the latter study, XBP1s mRNA was measured 
by Northern blot, a technique possibly not sensitive enough to detect 
the slight (64%), but significant increase that we observed.  
In response to ER stress, activated IRE1α recruits TRAF2 (tumor-
necrosis factor-α-receptor-associated factor 2). This complex induces 
the phosphorylation of JNK linking ER stress to inflammation 
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pathways (Urano et al., 2000). In our study, we showed an activation 
of the IRE1α pathway but no change was observed in the 
phosphorylation state of JNK. This inconsistent result could be 
explained by three hypotheses: 1) we missed a rapid and transient 
phosphorylation of JNK that could occur before 4 h; 2) the activation 
of the IRE1 pathway is too weak to induce JNK phosphorylation. 
Indeed, XBP1s, a direct marker of IRE1 pathway, increased slightly in 
comparison to others UPR markers; 3) IRE1 mediated-JNK activation 
is not present in C2C12 myotubes. To the best of our knowledge, this 
pathway has not been demonstrated in muscle cells.  
The most immediate response to ER stress is the translational 
inhibition of protein synthesis. Upon ER stress, PERK homodimerizes 
to promote its trans-autophosphorylation. The activation of PERK 
induces the phosphorylation of eIF2α, which inhibits global 
translation while activating selective translation (Lu et al., 2004). In 
agreement with previous results obtained in other cell types (Xue et 
al., 2005, Holtz et al., 2006), we observed that H2O2 induced eIF2α 
phosphorylation in C2C12 myotubes. However, we may not exclude 
that eIF2α could be phosphorylated independently of PERK upon 
oxidative stress. Four different kinases are known to phosphorylate 
eIF2α: PERK, general control non repressed 2 kinase (GCN2), heme-
regulated inhibitor kinase (HRI) and interferon-induced double-
stranded RNA-dependent protein kinase (PKR). The kinase that 
phosphorylates eIF2α under oxidative stress is still under debate. 
Some authors suggested the existence of another eIF2α-kinase 
specifically induced by oxidative stress (Ron, 2002, Harding et al., 
2003). Recently, a higher phosphorylation state of PERK was reported 
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upon H2O2 exposure in HeLa cells but on the opposite, in L929 
fibroblasts, other authors reported, no change in PERK 
phosphorylation state while the phosphorylation state of eIF2α was 
increased (Xue et al., 2005, Pallepati and Averill-Bates, 2011). 
Consequently, eIF2α phosphorylation induced by H2O2 is possibly 
mediated by PERK but we may not exclude a contribution of another 
kinase. 
ATF4 transcript is the most investigated UPR downstream effector 
translated under eIF2α phosphorylation. This transcription factor 
upregulates CHOP, the main mediator of ER-mediated apoptosis (Wu 
and Kaufman, 2006). Furthermore, ATF4 cooperates with CHOP to 
induce the transcription of TRB3 (Ohoka et al., 2005). Consistently 
with the activation of the PERK branch of UPR, we showed that the 
mRNA levels of ATF4, CHOP and TRB3 increased after H2O2 
exposure in C2C12 myotubes.  
The ER lumen provides an oxidizing environment, which allows 
the formation of disulfide bonds. At the end of these oxidation 
reactions, the electrons are finally transferred to oxygen to form H2O2 
inside ER. Therefore, a higher folding rate increases the production of 
H2O2 (Zhang and Kaufman, 2008), which subsequently can activate 
ER stress and UPR as shown in the present study. On the opposite, ER 
stress also regulates antioxidant defences (Harding et al., 2003). For 
example, the PERK pathway activates the transcription of glutathione 
S-transferase subunits favouring the redox buffer capacity of ER 
(Malhotra and Kaufman, 2007a). The activation of the PERK branch 
after H2O2 exposure that we observed is compatible with the idea that 
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ER has the capacity of sensing oxidative environment and to trigger 
antioxidant response. 
The third branch of UPR is initiated by the translocation of ATF6 
to the Golgi apparatus where it is cleaved by two proteases. The 
proteolysis releases a fragment containing a basic region and leucine 
zipper (bZIP) domain, which migrates to the nucleus, binds to ERSE 
and induces the transcription of UPR-inducible genes (Zhang and 
Kaufman, 2008). Activation of ATF6 can be assessed by measuring 
BiP dissociation, ATF6 translocation, ATF6 cleavage or ATF6 
transcriptional activity. The last strategy, used in our experiments, is 
recognized as a very sensitive method (Shen and Prywes, 2005). The 
lack of changes in the ATF6 transcriptional activity reported in the 
present study provides evidence against the activation of the ATF6 
branch of UPR by H2O2 in C2C12 myotubes. This is an apparent 
contradiction with the upregulation of the cleavage of ATF6 found in 
HeLa cells after H2O2 exposure (Pallepati and Averill-Bates, 2011). 
Therefore, in our study, we may not rule out a cleavage of ATF6 
without changing its transcriptional activity.  
In conclusion, ER of C2C12 myotubes appears to be able to sense 
and respond to oxidative stress. Nevertheless, H2O2-induced oxidative 
stress does not activate the three branches of UPR to the same extent. 
The downstream effectors of PERK i.e. eIF2α, ATF4, CHOP and 
TRB3 are highly responsive to oxidative stress. The IRE1 pathway is 
slightly activated whereas the transcriptional activity of ATF6 
pathway is not modified. The mechanisms by which branches of UPR 
can be specifically activated by oxidative stress are currently 
unresolved and need further investigations. 
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Chapter 8: Discussion, limitations and conclusion 
 
8.1. Discussion 
 
8.1.1. Regulation of endoplasmic reticulum stress, body mass, and 
insulin sensitivity by toll-like receptor 4 
 
TLR4 and ER stress 
High concentrations in lipids induce ER stress in many cell types 
including myocytes, hepatocytes and adipocytes (Flamment et al., 
2012). In those cells, disruption of ER homeostasis has been causally 
linked to insulin resistance physiopathology (Ozcan et al., 2006). 
However, little is known about the mechanism by which lipids act on 
ER. In the study presented in chapter 5, we hypothesized that TLR4 
mediates circulating NEFA-induced ER stress. To test this hypothesis, 
WT and TLR4-/- mice were fed with chow or HFD. Our results 
indicated that TLR4-/- mice were protected against ER stress in 
skeletal muscle, liver and adipose tissue. To investigate how TLR4 
regulates ER stress, we measured the TLR4 downstream effectors. 
Surprisingly, neither NF-κB nor MAPK pathways were activated by 
HFD. Except for the phosphorylation state of JNK in adipose tissue, 
none of the markers of the TLR4 pathway were upregulated by HFD 
in WT and TLR4-/- mice. Furthermore, no change was observed in 
circulating NEFA concentrations after HFD. These results argue 
against a direct regulation of ER stress by TLR4 signaling. However, 
we cannot exclude that 1) NF-κB and MAPK pathways were 
transiently activated after an acute elevation of circulating NEFA 
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concentrations caused by a high-fat meal, so we missed these changes 
because tissue and blood samples were taken in a fasted state; 2) our 
markers were not sensitive enough to detect an activation of the TLR4 
downstream effectors. 
 
In C2C12 myotubes, we clearly found a disconnection between 
TLR4 activation and ER stress (data not shown). TLR4 knockdown by 
siRNA failed to reduce ER stress induced by palmitate. On the other 
hand, in a time-course experiment (0-24 h), LPS (1 µg/ml) did not 
increase the mRNA levels of ATF4, CHOP, TRB3, XBP1s and BiP. 
On the contrary, LPS drastically increased the cytokines IL-6 (160-
fold) and monocyte chemotactic protein 1 (MCP1) (187-fold). In our 
experiment, the activation of TLR4 induced by LPS does not seem 
comparable with physiological conditions. For instance, IL-6 mRNA 
is upregulated no more than 3-fold in the vastus lateralis from obese 
subjects (Reyna et al., 2008), as well as in skeletal muscle of HFD-fed 
mice (Cani et al., 2007). This suggests that even if LPS and/or 
circulating NEFA activate TLR4, this regulation is probably not 
sufficient to trigger ER stress in muscle cells. Consequently, we 
propose that TLR4 does not act directly on ER homeostasis in muscle 
cells. This observation is probably cell-type specific. Indeed, LPS 
does induce ER stress in numerous cell types (chapter 2). More 
generally, cells with high secretory activity could be more sensitive to 
ER stress than those that are not specialized in protein secretion such 
as muscle cells. In most eukaryotic cells, about one-third of the 
proteins are synthetized in the ER (Hetz, 2012). However, the ER 
folding machinery of specialized secretory cells (e.g., hepatocytes, B 
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lymphocytes, pancreatic β cells, macrophages) faces additional 
challenges due to the high protein demand (Hetz, 2012). For instance, 
~80% of the proteins synthetized in pancreatic β cells are exported 
(Kramer and Poort, 1972) and, liver cells secrete millions proteins per 
minute (Hotamisligil, 2010). Consequently, we can imagine a 
threshold of ER stress adapted to cell functions. 
 
In our study, a direct relationship between TLR4 and ER stress 
seems unlikely. However, TLR4 is associated with ER stress as 
demonstrated by the use of knockout mice. Like others, we found that 
TLR4 deficiency protects against HFD-induced obesity (Tsukumo et 
al., 2007, Radin et al., 2008). Therefore, the protective effect observed 
on ER stress could be related to leanness rather than a direct TLR4 
signaling. Obesity is associated with numerous disorders that can alter 
ER homeostasis (e.g., inflammation, oxidative stress, mitochondrial 
dysfunction, lipotoxicity and glucotoxicity). In our study, obesity is a 
confounding factor that makes the results difficult to interpret.  
 
When lipids accumulate in the cytosol, more proteins are needed to 
store fat in lipid droplets (Hotamisligil, 2006). Consequently, ER 
stress could be due to an increase of protein synthesis. Alternatively, 
lipotoxicity can disrupt the folding capacity. Lipid excess is associated 
with ROS production in muscle cells, and it has been proposed, in 
other cell types, that oxidative stress induces ER stress (chapter 2). In 
the study reported in the chapter 6, we tested whether oxidative stress 
per se could induce ER stress in C2C12 myotubes. Interestingly, we 
showed that H2O2 triggers ER stress in C2C12 myotubes. We can 
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suppose that, like thapsigargin, oxidative stress alters calcium 
homeostasis by targeting ER-based calcium channel (chapter 2). 
However, we did not measure the calcium release from ER, thus we 
may not exclude the presence of another mechanism. For instance, the 
folding capacity and the ERAD system could be overwhelmed by the 
presence of proteins damaged by ROS. Whatever the mechanisms, our 
results provide an argument for the involvement of ROS in lipid-
induced ER stress in muscle cells. Recently, N-acetylcysteine and 
ebselen antioxidant molecules alleviated ER stress induced by NEFA 
in 3T3-L1 adipocytes (Kawasaki et al., 2012). However, using the 
natural antioxidant tetramethylpyrazine, we were unable to block 
palmitate-induced ER stress in C2C12 myotubes (data not shown). At 
the present time, we cannot propose that ROS are the intermediates by 
which lipids disrupt ER homeostasis in muscle cells. More research is 
required to test other antioxidant agents, and probably specific 
molecules targeting mitochondrial ROS could be helpful. Indeed, 
lipid-stimulated ROS production seems to be related to mitochondrial 
dysfunction (chapter 2). In different cell-types, the use of antioxidant 
agents enabled to reduce ER stress induced by various conditions 
(chapter 2), suggesting that oxidative stress could be a common 
mediator by which metabolic factors are sensed by ER. 
 
Modulation of energetic metabolism by TLR4 
The protective effect of TLR4 deficiency on obesity seems to be 
related to a higher energy expenditure rather than a decrease of energy 
intake. However, a reduction of fat absorption cannot be excluded in 
TLR4 deficient mice. To the best of our knowledge, this has not been 
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investigated yet. In agreement with Tsukumo et al. (2007), we found 
that energy intake increased in WT as well as TLR4-/- mice submitted 
to HFD (Tsukumo et al., 2007). On the other hand, measurements of 
oxygen consumption showed that, upon HFD, energy expenditure 
increases in TLR4 deficient compared to control mice (Tsukumo et 
al., 2007). Consequently, TLR4 is probably not involved in the 
regulation of appetite and satiety. Nevertheless, contrasting results 
have been reported. In HFD-fed mice, TLR4 or MyD88 knockdown 
reduced the caloric intake, suggesting that TLR4 regulates appetite 
(Galbo et al., 2013). These conflicting results remain difficult to 
explain.  
 
Interestingly, regulation of energetic metabolism emerges as a new 
function of TLR4 (Pang et al., 2010). Upon HFD, fatty acid oxidation 
increases in TLR4 deficient mice as shown by the reduction in the 
respiratory exchange ratio; this is not the case in the WT mice 
(Tsukumo et al., 2007). According to this finding, TLR4 deficient 
mice could adapt energetic substrate to diet composition. In line with 
Tsukumo et al. (2007), it has been reported a higher fatty acid 
oxidation capacity, beta-hydroxyacyl CoA dehydrogenase and citrate 
synthase activity in the skeletal muscle of TLR4 deficient mice 
(Frisard et al., 2010). Intraperitoneal injection of LPS in WT mice 
produced both an increase of glucose oxidation and a reduction of 
fatty acid oxidation in skeletal muscle (Frisard et al., 2010). In C2C12 
myotubes, IKK inhibitor prevented the shift in energetic substrate 
induced by low dose of LPS (50 pg/ml), suggesting an implication of 
NF-κB (Frisard et al., 2010). More investigations are needed to better 
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understand how TLR4 regulates energetic metabolism. 
 
In the context of HFD, not all studies found an implication of 
TLR4 in body weight gain. The reason of this discrepancy is unclear 
but a sex-dependent effect has been proposed since Shi et al. (2006) 
reported that, upon HFD, female TLR4-/- mice gain more weight than 
female WT mice (Shi et al., 2006). However, in another study, male 
TLR4-/- mice were not protected from body weight gain induced by 
HFD, suggesting no sex-dependent effect (Kim et al., 2007). 
Some authors proposed that the different genetic alterations 
existing in the TLR4 deficient mice could explain the divergent results 
obtained concerning obesity (Saberi et al., 2009, Tsukumo et al., 
2007). Three models of TLR4 deficient mice are available. Two of 
them are natural loss-of-function mutation (C3H/HeJ) or natural 
deletion (C57BL/10ScN). The third one, TLR4-/- mice, used in our 
study, have been generated by homologous recombination (Hoshino et 
al., 1999). The hypothesis of a specific adaptation related to the 
different genetic alterations might also be ruled out. In our study, male 
TLR4-/- mice were protected against body weight gain induced by 
HFD, whereas another study did not find such effect (Kim et al., 
2007). Similarly, conflicting results are present in the literature 
regarding C3H/HeJ mice (Tsukumo et al., 2007, Poggi et al., 2007) 
and C57BL/10ScN mice (Radin et al., 2008, Davis et al., 2008). It is 
currently difficult to explain such contradictory results, but differences 
in circulating LPS could be involved. Interestingly, HFD increases 
circulating LPS, and chronic infusion of LPS induces obesity in mice 
(Cani et al., 2007). As a consequence, LPS could be responsible of the 
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pathological adaptation discussed above. We can speculate that 
circulating LPS concentrations depend on HFD composition and 
period, inducing thereby differences in body weight gain. In the 
studies described in this paragraph, the percentage of calories from fat 
ranged from 45 to 60%, and the HFD period ranged from 7 to 36 
weeks. Complementary to this hypothesis, the source of fat could also 
be critical. Indeed, saturated NEFA, unlike unsaturated NEFA, are 
known to activate TLR4 (chapter 2). Thus, HFD composition could 
influence the concentration of circulating saturated NEFA, which in 
turn might regulate TLR4-induced obesity. In connection with this 
hypothesis, high-fat palmitate, unlike HFD control, upregulates IL-6 
and TNFα in mice adipose tissue (Davis et al., 2008). Unfortunately, 
the origin of fat is rarely indicated in the studies. 
 
Regulation of insulin sensitivity by TLR4 
In the last decade, TLR4 emerged as a candidate linking dietary fat 
intake to insulin resistance. However, results from the literature 
remain unclear. In HFD-fed mice, two studies reported a protective 
role of TLR4 deficiency on insulin resistance (Shi et al., 2006, 
Tsukumo et al., 2007), whereas two others did not find such effect 
(Poggi et al., 2007, Radin et al., 2008). These conflicting results could 
be explained by differences in HFD composition and period (see 
above), and/or techniques used to evaluate insulin sensitivity. Indeed, 
OGTT (Tsukumo et al., 2007), ITT (Shi et al., 2006, Radin et al., 
2008) or euglycemic-hyperinsulinemic clamp (Poggi et al., 2007) has 
been performed. In our study, we found that TLR4-/- mice are slightly 
less glucose intolerant than their WT counterparts after HFD. This is 
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in agreement with Tsukumo et al. (2007) although the effect on 
glucose tolerance was much more pronounced in that study. However, 
it is hazardous to compare our results with those obtained in that 
report due to differences in the HFD models. For instance, after only 8 
weeks on HFD, the body weight of WT mice increased by ~50% 
compared to control mice. In our study, 8 weeks of HFD did not 
change body weight (data not shown), this highlights major 
differences in HFD models. 
Inflammation seems to be the obvious mechanism by which TLR4 
mediates insulin resistance. In line with this hypothesis, TLR4 
deficient mice were protected against HFD-induced insulin resistance 
and inflammation in skeletal muscle, liver and adipose tissue (Shi et 
al., 2006, Tsukumo et al., 2007). However, in our study the 
inflammation markers were not upregulated by HFD. This 
discrepancy could be due to the severity of HFD-induced obesity. As 
mentioned above, body weight was drastically increased after HFD in 
the study of Tsukumo et al. (2007). Likewise, in the study of Shi et al. 
(2006) body weight increased by 60-70% in WT mice after HFD. In 
our experiment, body weight was increased by 18% in WT mice after 
HFD (data not shown). In another study, increase of body mass was 
limited to ~10% after HFD and, no change was observed in the 
mRNA levels of TNFα, MCP1 and IL-6 cytokines in the adipose 
tissue (Davis et al., 2008). Altogether, this suggests that only extreme 
models of HFD are associated with obesity-induced inflammation in 
mice. The link between TLR4, inflammation and insulin resistance 
remains to be demonstrated in more physiological conditions.  
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ER stress could also mediate the action of TLR4 on insulin 
sensitivity. As described in chapter 3, ER stress is recognized as a 
central mechanism of insulin resistance physiopathology. 
Interestingly, we found that TLR4-/- mice were protected against ER 
stress induced by HFD in the main organs for glucose metabolism. 
However, the results obtained do not allow to establish a link between 
ER stress and insulin resistance. Firstly, insulin resistance has not 
been demonstrated since insulin concentration during OGTT was not 
measured, and ITT was not performed. Secondly, the main 
intermediate of ER stress-induced insulin resistance, i.e., JNK (chapter 
3), was not activated by HFD except in the adipose tissue. In this 
tissue, the other markers of TLR4 signaling were not upregulated, 
supporting the idea of an ER stress-dependent activation of JNK. 
Regarding liver, ER stress stimulates lipogenesis through activation of 
the transcription factor sterol regulatory element binding protein 1c 
(Kammoun et al., 2009). This mechanism has been causally associated 
with liver insulin resistance (Kammoun et al., 2009). In our study, 
liver ER stress could potentially participate to glucose intolerance 
induced by HFD. The role of ER stress in skeletal muscle insulin 
resistance is particularly unclear. It will be discussed in the next 
subpart.  
Alternatively, ceramides could account for TLR4-induced insulin 
resistance. Until recently, it was well accepted that saturated NEFA 
induced de novo ceramides synthesis by providing a substrate for SPT, 
the rate limiting enzyme of ceramide synthesis. A paper published in 
The Journal of Clinical Investigation demonstrated that saturated 
lipids also promote de novo ceramide synthesis through TLR4 
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(Holland et al., 2011). The authors provide evidences that can be 
summarized as follows: 1) LPS time-dependently increased ceramides 
content in isolated rat soleus; 2) In soleus, TLR4 deficient mice were 
protected against accumulation of ceramides induced by lard oil 
infusion or palmitate treatment; 3) LPS as well as palmitate 
upregulated enzymes driving ceramide biosynthesis such as SPT2, 
ceramide synthase 1 (CerS1), CerS2 and CerS6 in C2C12 myotubes. 
As mentioned in chapter 3, ceramides are mediators of lipid-induced 
insulin resistance. Collectively, these observations suggest the 
existence of another mechanism by which TLR4 could act on insulin 
sensitivity. 
 
The use of global deficiency in TLR4 leads to difficulties when 
interpreting the results: 1) confounding effect obesity; 2) identification 
of the tissue responsible for the protective effect observed. A well-
designed study tried to overcome these drawbacks (Jia et al., 2014). 
Liver-specific TLR4 null mice (TLR4LKO) were generated thanks to a 
Cre-LoxP system. Under HFD, TLR4LKO mice became obese as WT 
mice, suppressing de facto the confounding factor of obesity. 
Interestingly, HFD-induced insulin resistance was attenuated in 
TLR4LKO. Consequently, liver seems a key organ in which TLR4 
exerts its deleterious effects on insulin signaling. However, 
contradictory results were reported (Galbo et al., 2013). Indeed, in this 
study, TLR4 deficient mice were not protected against liver insulin 
resistance induced by HFD. This suggests major differences in the 
physiopathology of insulin resistance between global and liver-
specific TLR4 knockout. 
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Macrophage infiltration is well known to play a central role in the 
development of insulin resistance (Shoelson et al., 2006). In the 
context of obesity, proinflammatory cytokines can be mainly 
produced by the infiltrated macrophages. For instance, TNFα is 
essentially synthetized by macrophages in adipose tissue from ob/ob 
mice (Weisberg et al., 2003). Given that macrophages highly express 
TLR4 and contribute to insulin resistance, myeloid-specific TLR4 null 
mice (TLR4∆mϕ) were generated (Jia et al., 2014). Unexpectedly, after 
HFD, TLR4∆mϕ were not protected against insulin resistance and, 
circulating inflammatory cytokines were elevated. In mice, 
hematopoietic cell-specific deletion of TLR4 provided divergent 
results (Saberi et al., 2009). According to this observation, TLR4 from 
lymphoid-derived cells rather than from macrophages could be 
involved in the physiopathology of insulin resistance. 
 
In response to high level of circulating NEFA, metabolic tissues 
trigger an inflammatory response which in turn disrupts insulin 
signaling. Interestingly, a plasma membrane receptor of the innate 
immune system, TLR4, induces inflammation in response to saturated 
NEFA. In the wake of this discovery, studies demonstrated the 
implication of TLR4 in the development insulin resistance. However, 
it remains to unravel the tissues and cells contributing to this 
mechanism. 
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8.1.2. Insulin resistance induced by endoplasmic reticulum stress 
in muscle cells: what is wrong?  
 
UPR, inflammation and insulin resistance 
In the context of obesity, extracellular and intracellular lipids 
appear to initiate the development of metainflammation, i.e., 
inflammation induced by metabolic factors. This abnormal 
inflammation, also called low-grade inflammation, must be 
distinguished from the normal response to pathogen infection. In type 
2 diabetes, the development of insulin resistance is intimately linked 
to metainflammation (Hotamisligil, 2005), this causal relationship has 
been discovered for over a hundred years. Indeed, in 1876 Ebstein 
observed that sodium salicylate reduced glycosuria in diabetic subjects 
(Shoelson et al., 2006). However, the mechanisms by which metabolic 
signals are transduced into inflammatory response remain unclear and 
belong to the emerging field of immunometabolism. Recently, it has 
been proposed that ER could be an integration center, which senses 
metabolic stress and triggers an inflammatory signal (Hotamisligil, 
2010, Hotamisligil, 2006). More precisely, UPR signaling is coupled 
with the NF-κB and MAPK inflammatory pathways (Zhang and 
Kaufman, 2008). In the next paragraphs, we will focus on the 
experiments that revealed this mechanism.  
 
Urano et al. (2000) treated rat pancreatic AR42J cells with 
tunicamycin and thapsigargin (Urano et al., 2000). They observed that 
JNK activity was drastically increased by both chemical ER stress 
inducers. Upon ER stress, IRE1α recruits the adapter protein TRAF2, 
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the complex IRE1α-TRAF2 activates JNK. This was the first time that 
ER stress was connected to JNK. These findings were extended to 
fibroblasts and liver cells (Ozcan et al., 2004). IRE1α-/- fibroblasts 
were protected against JNK activation induced by tunicamycin. 
Because JNK is well known to phosphorylate IRS-1 on an inhibitory 
serine residue (Ser307), insulin pathway was also investigated. In Fao 
liver cells, tunicamycin disrupts insulin signaling as shown by the 
increase of phospho-IRS-1 (Ser307), and the reduction of both 
phospho-Akt and phosphotyrosine-IRS-1 levels. Addition of a JNK 
inhibitor, SP600125, to tunicamycin restored insulin signaling. In 
wild-type fibroblasts, tunicamycin blocked insulin-induced IRS-1 
phosphorylation on tyrosine residue, whereas such effect was not 
found in IRE1α-/- fibroblasts. All together, these results have 
established the principal mechanistic basis by which UPR disrupts 
insulin signaling, a pathway that we can called IRE1α-TRAF2-JNK-
IRS-1.  
In addition to JNK, UPR has been connected to NF-κB pathway 
(Hu et al., 2006). Similar to the mechanism described above, IRE1α 
activation leads to the formation of a complex IRE1α-TRAF2-IKK, 
resulting in the activation of IKK, another inflammatory kinase well 
known to impair insulin signaling through IRS-1 serine 
phosphorylation (chapter 3). In different cancer cell lines, tunicamycin 
as well as thapsigargin activate IKK as shown by the increase of 
phospho-IκBα and the decrease of IκBα levels. IRE1α knockdown 
protected against IKK activation, demonstrating that IRE1α is 
upstream of IKK. 
JNK and IKK are at the interface between UPR and insulin 
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signaling. However, activation of JNK and IKK by IRE1α has been 
demonstrated only with non-physiological ER stress inducers. 
Furthermore, such connection has not been explored in skeletal 
muscle, a major site of insulin resistance. 
 
In our study, ER stress was induced by palmitate and we used 
C2C12 myotubes as a model of muscle cells. In C2C12 and L6 
myotubes, numerous studies demonstrated that palmitate inhibits 
insulin signaling, glucose uptake and glycogen synthesis (Hage 
Hassan et al., 2012, Yuzefovych et al., 2010, Chavez et al., 2003, 
Chavez and Summers, 2003, Lee et al., 2006). On the other hand, 
results from our lab and others demonstrated that palmitate induces 
ER stress in C2C12 myotubes (Deldicque et al., 2010, Salvado et al., 
2013, Hage Hassan et al., 2012). Our experiment confirms these 
findings. In addition, palmitate activated the IRE1α-JNK pathway in 
C2C12 myotubes. Indeed, palmitate increased the phosphorylation 
state of the JNK downstream target c-Jun and, IRE1α knockdown 
prevented this effect. However, palmitate did not modify phospho-
JNK level. This apparent discrepancy seems related to differences in 
the duration of the phosphorylation states. For instance, JNK 
phosphorylation induced by interleukin 1β is transient (30 min), 
whereas the phosphorylation state of c-Jun persists after 2 h in smooth 
muscle (Zhang et al., 2012). Although IRE1α knockdown protected 
against JNK activation, it did not prevent the inhibitory effect of 
palmitate on Akt. This suggests that JNK do not act on insulin 
pathway in C2C12 myotubes. As a consequence, the IRE1α-JNK-IRS-
1 pathway probably does not exist in muscle cells. 
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Early studies on JNK and metabolism pointed out the central role 
of this kinase in the physiopathology of insulin resistance (Hirosumi et 
al., 2002, Hotamisligil, 2005). Remarkably, inflammation, ER stress 
and oxidative stress converge toward JNK. JNK activity is drastically 
increased in liver, adipose tissue and skeletal muscle of obese mice 
(Hirosumi et al., 2002). JNK1 knockout ob/ob mice do not develop 
insulin resistance. However, those mice are also protected against 
body weight gain, probably via effects on energy expenditure 
(Hirosumi et al., 2002). Once again, the confounding factor of obesity 
makes difficult to identify the mechanism by which JNK1 acts on 
insulin signaling. Interestingly, in HFD-fed mice, activation of JNK in 
skeletal muscle was less clear than in adipose tissue and liver 
(Hirosumi et al., 2002). Furthermore, phospho-JNK level was not 
upregulated in skeletal muscle of type 2 diabetic subjects and HFD-
fed mice (Koh et al., 2013). In relation with these observations, the 
role of JNK in skeletal muscle insulin resistance has been recently 
challenged (Pal et al., 2013). Indeed, muscle-specific overactivation of 
JNK failed to disrupt insulin signaling and to modify the OGTT 
response in mice. On the other hand, muscle-specific JNK1 deficient 
mice were not protected against HFD-induced insulin resistance as 
shown by OGTT, ITT and insulin-stimulated Akt phosphorylation in 
skeletal muscle. However, in a similar experiment, contradictory 
results have been reported (Sabio et al., 2010). Consequently, the 
contribution of JNK to skeletal muscle insulin resistance is not clear at 
the moment. 
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In the study from Hage Hassan et al. (2012), the authors suggested 
that only non-physiologic ER stress can disrupt insulin signaling in 
muscle cells. Indeed, chemical chaperone prevented insulin resistance 
induced by tunicamycin but not by palmitate. To support this finding, 
they showed that both IRE1α and JNK phosphorylation states 
increased much more with tunicamycin than palmitate (Hage Hassan 
et al., 2012). To test whether non-physiologic ER stress could activate 
IRE1α-JNK pathway in a higher extent, we used thapsigargin (data 
not shown). It has been showed in our lab that thapsigargin (17 h, 200 
nM) induces a higher level of ER stress than palmitate (17 h, 1 mM) 
in C2C12 myotubes (Deldicque et al., 2010). In our experiment, 1 µM 
thapsigargin for 17 h increased 2-fold more XBP1s than palmitate. 
Although short (1-4 h) and long period (17 h) of incubation with 
thapsigargin produced a massive ER stress, JNK was not activated. 
Indeed, the phosphorylation state of JNK was not modified, whereas 
phospho-c-Jun level was drastically reduced mainly because of a 
decrease of its total form. As shown by the use of siRNA, the effect of 
thapsigargin on phospho-c-Jun was independent of IRE1α. 
Consequently, insulin resistance induced by thapsigargin is unlikely 
related to IRE1α-JNK pathway. Nevertheless, tunicamycin for 16 h or 
24 h increased the phosphorylation state of JNK in C2C12 myotubes 
(Hage Hassan et al., 2012, Panzhinskiy et al., 2013). According to 
these observations, two different chemical ER stress inducers regulate 
JNK in an opposite way. Although difficult to explain, these results 
indicate that ER stress response would greatly depend on the stressor 
agent.  
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In the study presented in chapter 7, we have also evaluated the 
connection between IRE1α and NF-κB pathway (data not shown). In 
order to test the causal relationship between IRE1α and IKK in C2C12 
myotubes, we measured two downstream target of IKK, IκBα and the 
p65 subunit of NF-κB (data not shown). Upon IKK activation, IκBα is 
degraded and the p65 subunit of NF-κB is phosphorylated on Ser536 
(Sakurai et al., 2003). Although 17 h thapsigargin decreased IκBα 
level, IRE1α knockdown did not modify this effect. Furthermore, the 
phosphorylation state of NF-κB p65 was not changed by 1-4 h and 17 
h incubation with thapsigargin. Collectively, our results suggest no 
link between IRE1α and NF-κB pathway in C2C12 myotubes. 
However, we did not measure other markers of the NF-κB pathway 
such as phospho-IκBα, phospho-IKKα/β and NF-κB DNA binding 
activity. Therefore, we cannot definitively conclude that the NF-κB 
pathway is not under the control of IRE1α. Further researches are 
needed to describe more clearly the relationship between IRE1α and 
the NF-κB pathway in muscle cells. 
 
TRB3 and insulin resistance 
Alternatively to the hypothesis tested above, ER stress can disrupt 
insulin signaling through the upregulation of TRB3 (chapter 3). In our 
experiment, we observed an inverted relation between TRB3 mRNA 
level and insulin signaling under palmitate treatment. Consequently, 
we decided to downregulate TRB3 to evaluate its role in palmitate-
induced insulin resistance. TRB3 siRNA did not restore Akt 
inhibition, suggesting no link between TRB3 expression and Akt 
phosphorylation state in C2C12 myotubes treated with palmitate. This 
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finding is in disagreement with those reported elsewhere. The 
interaction between TRB3 and Akt has been confirmed in mice 
skeletal muscles (Koh et al., 2006). Furthermore, in mice tibialis 
anterior, TRB3 overexpression inhibited the insulin pathway (Koh et 
al., 2013). However, the results obtained in that study are not totally 
convincing. In Figure 2d, the reduction of phospho-Akt (Thr308) level 
induced by TRB3 overexpression is only a trend. In supplementary 
Figure S3, TRB3 overexpression did not reduce phospho-Akt (Ser473) 
level after insulin stimulation. In the same study, the authors showed 
that TRB3 siRNA restored the inhibitory effect of tunicamycin on 
insulin-induced glucose uptake in C2C12 myotubes. However, the 
action of TRB3 siRNA on Akt phosphorylation sate was not shown 
despite the fact that TRB3 is known to inhibit the latter. The authors 
demonstrated a new inhibitory interaction of TRB3 with IRS-1. 
Consequently, the mechanism by which TRB3 reduced glucose uptake 
upon tunicamycin treatment could be due to IRS-1 and/or Akt 
inhibition. In our study, we did not measure insulin signaling at the 
level of IRS-1, so we cannot know whether TRB3 acts on IRS-1. 
However, given that IRS-1 is upstream of Akt, we can suppose that 
TRB3 did not inhibit IRS-1 in our model.  
Strikingly, one year after the report from Koh et al. (2013), the 
same laboratory published a paper showing contradictory results (An 
et al., 2014). In this study, TRB3 was overexpressed specifically in 
skeletal muscles of mice. Surprisingly, those mice were not insulin-
resistant as shown by OGTT, ITT, and insulin-stimulated Akt and 
IRS-1 tyrosine phosphorylation in skeletal muscle. According to the 
authors, these conflicting results could be explained by a chronic vs 
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acute adaptation to TRB3 overexpression. 
Although some conflicting results appear in the literature, TRB3 
overexpression inhibits insulin-stimulated Akt phosphorylation and 
glucose uptake in muscle cell lines (Liu et al., 2010, Koh et al., 2006). 
Furthermore, as noticed above, TRB3 siRNA reversed tunicamycin-
induced insulin resistance (Koh et al., 2013). These findings are not in 
agreement with our study. However, differences in the level of TRB3 
induction could explain such conflicting results. Indeed, in C2C12 
myotubes, TRB3 mRNA was much more increased with tunicamycin 
than palmitate (Hage Hassan et al., 2012). On the other hand, 
overexpression techniques produce a drastic upregulation of TRB3 
protein (Liu et al., 2010, Koh et al., 2006). According to western blot 
detection, Akt is much more expressed than TRB3 in C2C12 
myotubes. Indeed, TRB3, unlike Akt, is never detected in the control 
condition (Koh et al., 2013). Consequently, we can imagine that only 
a massive induction of TRB3 is able to block Akt. Although TRB3 
increases with palmitate, Akt expression could remain in a large 
excess compared to TRB3. In this unfavorable stoichiometry, TRB3 
might not be able to inhibit Akt.  
We cannot exclude that TRB3 do not interact with Akt. Indeed, a 
study published in the Biochemical Journal casts a doubt (Iynedjian, 
2005). In hepatocytes, TRB3 was overexpressed with a molar excess 
of ~25-fold over Akt. This drastic increase of TRB3 did not affect 
insulin-stimulated Akt phosphorylation (Thr308 and Ser473). These 
results are in opposition with those reported by Du et al. (2003) who 
were the first to show an interaction between TRB3 and Akt (Du et 
al., 2003). It remains difficult to explain such a discrepancy. 
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In our experiment, the results obtained are incomplete since we 
were unable to detect the protein level of TRB3. TRB3 was 
undetectable despite the use of three commercial antibodies (Santa 
Cruz, Calbiochem and Atlas). We tested them with positive 
(thapsigargin, palmitate and tunicamycin) and negative (TRB3 
siRNA) controls without success. As a consequence, TRB3 protein 
knockdown is maybe too weak to restore insulin signaling.  
 
In addition, conclusions of our study are limited by the absence of 
physiological measures such as glucose uptake or glycogen synthesis. 
We measured glucose uptake, but the effect of insulin was weak 
(~40%) (data not shown). When we added palmitate and siRNA, intra- 
and inter-variability were increased and the results were not 
interpretable. As already reported, insulin slightly increases glucose 
uptake in C2C12 myotubes, maybe because these cells do not have the 
complete machinery for glucose transport (Chavez and Summers, 
2003).  
 
ER stress and insulin resistance 
Our study supports recent results demonstrating no link between 
physiological ER stress and insulin resistance in muscle cells. Indeed, 
insulin resistance induced by palmitate is not prevented by PBA, 
TUDCA, or BiP overexpression in C2C12 myotubes (Hage Hassan et 
al., 2012, Rieusset et al., 2012). This is not in line with in vivo data. In 
ob/ob mice, chemical chaperones increased glucose uptake in skeletal 
muscle (Ozcan et al., 2006). A systemic effect could reconcile in vitro 
and in vivo data. Indeed, chemical chaperones reduce glycaemia, 
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insulinemia and maybe inflammatory cytokines. This might affect 
skeletal muscle insulin sensitivity independently of ER stress. 
Furthermore, in the study from Ozcan et al. (2006), ER stress was not 
assessed in skeletal muscle. Consequently, it is not possible to 
associate glucose uptake to ER stress in this tissue. 
Contrary to physiological ER stress, chemically-induced ER stress 
is well known to impair insulin action in muscle cells. Indeed, 
TUDCA reduced insulin signaling impairment induced by 
tunicamycin in C2C12 myotubes (Hage Hassan et al., 2012). 
According to these findings, the authors proposed that only a massive 
ER stress induces insulin resistance in muscle cells. Importantly, these 
observations challenge the conclusions drawn in previous studies 
using chemical ER stress inducers. What is the physiological 
relevance of the results obtained with these agents? As already noticed 
in this chapter and the chapter 3, in vitro, the link between UPR, 
inflammation, and insulin signaling is based on experiments using 
tunicamycin or thapsigargin. The conclusions from these studies 
should be carefully compared to physiological mechanisms. Although 
Hotamisligil is probably the author who contributed the most to 
establish the relationship between UPR and insulin signaling, he 
recently wrote: “Notably, the extreme level of ER stress induced by 
tunicamycin is not physiological and is beyond what the liver 
experiences during metabolic fluctuations or even in most disease 
states”, further: “We may be able to better understand the metabolic 
impact of ER stress by distinguishing between a physiological setting 
for the UPR (high glucose, dietary exposure, or lactation) and an 
extreme, death-inducing UPR (for example, liver cells treated with 
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tunicamycin)” (Hotamisligil, 2010). In line with these 
recommendations, chemical ER stress inducers should be used as a 
positive control and not as a model of physiological ER stress.  
Independently of ER stress, intramuscular ceramides have been 
proposed to mediate saturated NEFA-induced insulin resistance in 
muscle cells (Hage Hassan et al., 2012, Schmitz-Peiffer et al., 1999). 
Upon saturated NEFA exposure, ceramides content increases through 
de novo synthesis and maybe through an indirect regulation mediated 
by TLR4 (see 8.1.1). In muscle cells, ceramides are known to inhibit 
insulin signaling at the level of Akt (chapter 3). In addition to 
intramuscular ceramides, recent findings suggested a role of 
circulating ceramides in skeletal muscle insulin resistance. Circulating 
ceramides are elevated in type 2 diabetic patient (Boon et al., 2013). 
In lean mice, infusion of low density lipoproteins associated with 
ceramides induced insulin resistance specifically in the skeletal 
muscle (Boon et al., 2013). However, transport, regulation and action 
mechanism of circulating ceramides remain poorly understood. 
 
8.1.3. Immunometabolism: an evolutionary point of view 
Host defense and metabolism have been historically seen as two 
distinct disciplines. In education, this separation is used for didactic 
purposes, but this hides a highly integrated system. The research field 
of immunometabolism studies the mechanism by which immune 
system influences metabolism and vice versa. Immune and metabolic 
responses share numerous signaling pathways. For instance, TLR4 is 
expressed in non-immune cells and recognizes exogenous as well as 
endogenous ligands. In addition to inflammatory response, TLR4 
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engagement leads to metabolic changes in these cells (see above). 
Some proinflammatory cytokines possesses their own receptor in non-
immune cells, for instance, the tumor necrosis factor receptor (TNFR) 
for TNFα. TNFR activation induces insulin resistance through 
JNK/IKK (Hotamisligil, 2005). Furthermore, metabolic tissues are 
infiltrated by numerous immune cells. In liver, 5% of total cells are 
the resident macrophages Kupffer cells (Shoelson et al., 2006). 
Macrophage infiltration in adipose tissue seems to initiate 
inflammation-induced insulin resistance (Shoelson et al., 2006). 
Finally, ER appears as a key integrator, which transduces metabolic 
signal into inflammatory signal (Hotamisligil, 2006). 
Strikingly, in this work we found two examples showing no 
relationship between immune and metabolic systems in muscle cells. 
First, ER stress was not present after LPS treatment. Second, IRE1-
JNK pathway does not seem related to insulin resistance. In 
hepatocytes and adipocytes these two mechanisms have been shown 
(Alhusaini et al., 2010, Zhang et al., 2006, Ozcan et al., 2004). Why 
does it not work in muscle cells? To speculate on this question, it 
could be interesting to take into account the evolution of species. 
Sensing nutrients as well as defense against pathogen appear the most 
fundamental requirements for living organisms. In lower species both 
systems are integrated. For instance, adipose tissue from Drosophilia 
contains immune cells and the equivalent of mammalian liver 
(Hotamisligil, 2006). This structure is known as “fat body”. In more 
evolved species, liver and adipose tissue are independent organs, 
whereas immune cells are ubiquitous. Thus, we can imagine a close 
relation between immune system and metabolism in liver as well as in 
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adipose tissue. This interaction could be less important in skeletal 
muscle. In the literature some observations support such idea, but this 
remains hypothetical. In mice, hematopoietic cell-specific deletion of 
TLR4 protected against insulin resistance in liver and adipose tissue, 
but not in skeletal muscle (Saberi et al., 2009). This suggests that 
interactions between immune cells and muscle cells are not a main 
component of insulin resistance in this tissue. In line with this result, 
skeletal muscle is less infiltrated by macrophages than liver and 
adipose tissue (Saberi et al., 2009). Interestingly, the key proteins 
linking inflammation to insulin resistance (IKKβ, NF-κB, PKCθ and 
JNK) were specifically altered in skeletal muscle by genetic 
manipulation. Contrary to heterozygous IKKβ mice, muscle-specific 
knockout mice for IKKβ were not protected against obesity-induced 
insulin resistance (Rohl et al., 2004, Yuan et al., 2001). In mice, 
muscle-specific inhibition of NF-κB did not prevent insulin resistance 
induced by HFD. Furthermore, overactivation of NF-κB in skeletal 
muscle does not lead to insulin resistance (Cai et al., 2004). As 
noticed in chapter 3, mice expressing a muscle-specific dominant-
negative of PKCθ are obese and insulin-resistant. Finally, JNK 
muscle-specific deficiency furnished controversial results (see 8.1.2). 
Taken together, these observations suggest that skeletal muscle 
inflammation is not a major component of insulin resistance 
physiopathology. 
 
It would be interesting to compare immunometabolism network in 
each cell types in order to better understand insulin resistance. It will 
probably lead to unravel many distinct types of insulin resistance.  
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8.2. Limitations 
In almost all the studies found in the literature, including those 
presented herein, UPR is used as marker of ER stress. Consequently, 
we make the hypothesis that UPR or ER stress evaluation leads to the 
same result. This assumption can be formulated as follows: ER stress 
activates UPR and, accordingly, ER homeostasis can be assessed by 
measuring UPR. Is it always true? The question deserves to be asked 
and a preliminary answer will be exposed in the next paragraphs.  
The main mechanism of UPR activation is based on the release of 
BiP from the ER stress sensors (PERK, IRE1α and ATF6) when 
unfolded proteins accumulate inside the ER (chapter 1). This is clearly 
an oversimplification and additional mechanisms have been proposed 
(Hotamisligil, 2010). Nevertheless, BiP detachment actives the three 
ER stress sensors. Consequently, if ER stress is present, the three UPR 
pathways should be activated. However, some studies reported a 
selective activation of UPR branches, suggesting thereby a 
disconnection between ER stress and UPR, and/or additional sensing 
mechanisms of ER stress.  
In macrophages, TLR4 or TLR2 activation induced the splicing of 
XBP1 independently of ER stress as shown by the absence of effect 
on phospho-PERK, cleaved ATF6 protein levels and BiP, PDI, CHOP 
mRNA levels (Martinon et al., 2010). In L929 fibroblasts, H2O2 or 
arsenite induces the phosphorylation of eIF2α, whereas no change was 
observed in the phosphorylation state of PERK and the spliced form 
of XBP1 (Xue et al., 2005). Collectively, these findings suggest that, 
in particular conditions, UPR could be activated independently of ER 
stress.  
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Furthermore, UPR signaling is subject to regulation. eIF2α and 
ATF6 activations can be uncoupled from ER stress. In addition to 
PERK, three kinases are upstream of eIF2α: GCN2, HRI and PKR. 
HRI function is restricted to erythroid cells, whereas GCN2 is 
activated by amino acid deprivation and UV irradiation (Dey et al., 
2010). In addition to double-strand RNA, PKR responds to ER stress, 
inflammatory mediators and nutrients (Nakamura et al., 2010, 
Hotamisligil, 2010). Consequently, this kinase integrates multiple 
signals and can activate eIF2α independently of ER stress. Regarding 
ATF6, it has been reported that p38 phosphorylates the cleaved form 
of ATF6 and enhances its transcriptional activity in HEK-293 cells 
and primary ventricular myocytes (Luo and Lee, 2002, Thuerauf et al., 
1998). It has also been reported that peroxisome proliferators-activator 
receptor gamma coactivator-1 alpha (PGC-1α) modulates UPR 
through coactivation of ATF6 transcriptional activity in mice skeletal 
muscle (Wu et al., 2011). More generally, ATF4/ATF6/XBP1 form 
dimers with numerous partners, which are either activators or 
repressors (Schroder and Kaufman, 2005). According to these 
observations, two limitations appear when UPR is used to monitor ER 
stress: 1) phosphorylation of eIF2α is not specific to PERK activation; 
2) UPR-inducible genes can be regulated independently of ER stress. 
Therefore, care must be taken when interpreting UPR as a marker of 
ER stress. Nevertheless, the spliced form of XBP1 seems to be the 
more specific marker of ER stress, except in macrophages (see above). 
In the study presented in chapter 6, the pattern of UPR activation 
deserves a particular attention. To the best of our knowledge, the 
splicing of XBP1 by IRE1α is specifically dependent on ER stress in 
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muscle cells. Consequently, we supposed that H2O2 induced ER stress 
in C2C12 myotubes. However, we found a partial and unequal 
activation of UPR, the PERK signaling was much more activated than 
the IRE1α branch, while the AT6 pathway was probably unaffected by 
H2O2. In a general view, sensing and responding to ROS at the level 
of ER is a well-adapted mechanism to manage oxidative stress 
induced by protein folding reactions (chapter 1). According to our 
results, the PERK branch is probably specialized in the detection of 
oxidative stress. This is consistent with the antioxidant response 
triggered by this pathway (chapter 1). In our study, we supposed that 
PERK is activated by ER stress, and in turn phosphorylates eIF2α. 
Because we were not able to measure phospho-PERK despite using 
positive control (data not shown), we cannot rule out the involvement 
of other kinases. Results from the literature can give some clues. No 
evidences indicate an activation of GCN2 by oxidative stress. 
Although PKR does not seem activated by oxidative stress, one study 
reported that H2O2 upregulates its expression at the transcriptional 
level in human T lymphocyte cells (Pyo et al., 2008). Thus, instead or 
in addition to PERK this kinase could be involved in H2O2-induced 
eIF2α phosphorylation. A fifth kinase of eIF2α, specifically activated 
by oxidative stress, has been proposed by David Ron (Ron, 2002). 
This kinase has currently not been identified. PERK is probably 
activated under oxidative stress, but this remains controversial. In 
fibroblast cells, H2O2 induced eIF2α phosphorylation without PERK 
activation (Xue et al., 2005). However, PERK is phosphorylated after 
H2O2 treatment in HeLa cells (Pallepati and Averill-Bates, 2011). The 
mechanism by which ER senses oxidative stress is still unclear. In our 
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study, the pattern of UPR activation suggests that ER possesses a 
specific mechanism to detect oxidative stress. However, the absence 
of data on PERK and PKR is clearly a limitation for our study. 
It should be interesting to compare in situ ER homeostasis to UPR 
signaling under various stresses. Interestingly, researchers used the 
secreted alkaline phosphatase (SEAP) system to monitor ER stress in 
situ (Hiramatsu et al., 2006). Cells were transfected with a reporter 
gene coding for a truncated form of the human placental alkaline 
phosphatase. This protein is secreted due to the removal of the 
membrane anchoring domain. Then, the activity of alkaline 
phosphatase is measured by chemiluminescence directly in the 
medium. SEAP activity is dose-dependently reduced by chemical ER 
stress inducers. Alternatively, morphological modification of ER has 
already been used to estimate ER stress in parallel with UPR markers. 
Indeed, ER is dilated when unfolded proteins accumulate inside it. For 
instance, TNFα as well as tunicamycin induce ER dilatation as shown 
by electron microscopy (Xue et al., 2005). To extend our knowledge 
on ER stress, it will be interesting to develop new strategies allowing 
to monitor the amount of unfolded proteins. 
 
Another limitation of this work is the use of palmitate in non-
physiological conditions (chapter 7). Palmitate is the most abundant 
saturated NEFA in the blood (Chavez and Summers, 2003). In human, 
the plasmatic concentration of palmitate ranges from ~100 µM 
(healthy subjects) to ~200 µM (obese subjects) (Yi et al., 2007). 
Although these values are subject to large interindividual variability, 
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the concentration of palmitate used in our study (1 mM) exceeds the 
physiological range.  
Furthermore, interaction between saturated and unsaturated NEFA 
metabolism regulates their effect on insulin pathway. In C2C12 
myotubes, palmitate alone induces insulin resistance, whereas this 
deleterious effect is prevented by addition of oleate (Salvado et al., 
2013, Coll et al., 2008). Interestingly, palmitate incorporation into 
lipid-derived toxic metabolites, such as ceramides and DAG, 
decreases when it is co-supplemented with unsaturated NEFA. In 
human myoblast exposed to palmitate, addition of oleate preventes 
ceramides and DAG increase, two well-known mediators of lipid-
induced insulin resistance (chapter 3) (Pickersgill et al., 2007). 
Consequently, the use of palmitate without unsaturated NEFA is far to 
mimic perfectly the real physiological conditions. 
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8.3. Conclusion 
In the context of obesity, extracellular and intracellular lipids exert 
dramatic effects on cellular processes. Here, we investigated the 
mechanism by which lipids disrupt ER homeostasis. We show that a 
receptor of the innate immune system, TLR4, could indirectly mediate 
lipid-induced ER stress in skeletal muscle, liver and adipose tissue. In 
addition, our work highlights that ER stress is activated by oxidative 
stress in muscle cells. This provides an argument to propose ROS as 
common intermediates by which metabolic factors alter ER 
homeostasis.  
In muscle cells challenged with lipid, we were interested by the 
consequence of ER stress on insulin signaling. Although ER 
homeostasis plays a central role in insulin resistance physiopathology, 
results from the literature are particularly conflicting in muscle cells. 
We show that, contrary to other cell types, muscle cells do not seem to 
possess the signaling mechanism linking UPR to insulin resistance.  
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